Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
T cell receptor signaling in naive CD4+ T cells	13/67	4.582624949781842E-10	4.2068497038997313E-7	0	0	12.521719858156029	269.2617917205738	MAP4K1;DBNL;STK39;WAS;SLA2;VAV1;CDC42;SH3BP2;AKT1;FLNA;CSK;PTPN6;HRAS
Mitotic G1-G1/S phases	17/135	1.1487083780470517E-9	5.272571455235967E-7	0	0	7.549229998177511	155.3980887476947	CDKN2D;CDT1;RPA1;CDC25A;PSMB10;PSMB8;PSMB9;CCND3;PSMB4;CDK6;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;E2F2;E2F4
Apoptosis	22/242	2.336198829741476E-9	7.148768419008917E-7	0	0	5.283651226158038	105.0111978584743	DBNL;PRF1;HMGB2;PIK3CD;IRAK4;PSMB8;PSMB10;PSMB9;PSMB4;PPP3CC;PSMB2;PSMC3;PSMC1;PSMD3;CAPN2;AKT1;PSME2;CAPN1;BAK1;PRKACA;MYD88;PLEC
Integrin signaling pathway	17/155	9.718276718526886E-9	2.23034450690192E-6	0	0	6.448515661524077	118.97032610328633	VASP;ITGB1;ARPC1B;WAS;ARPC4;ARPC5;ACTB;CDC42;CAPNS1;CAPN2;RAC2;ZYX;AKT1;CSK;CAPN1;TLN1;HRAS
Actin cytoskeleton regulation	20/226	1.989433849815327E-8	3.65260054826094E-6	0	0	5.105638435025127	90.5374216940876	CYFIP2;ITGB1;ARPC1B;LIMK2;WAS;PIK3CD;ARPC4;ARPC5;ACTB;VAV1;PPP1CA;CDC42;CFL1;RAC2;PIP4K2B;NCKAP1L;ITGB7;CSK;PFN1;HRAS
Interleukin-2 signaling pathway	42/847	2.8277146781266284E-8	4.326403457533742E-6	0	0	2.8276155870191704	49.147385669249736	ACAA2;RGS19;CTSZ;PRF1;PIK3CD;LRMP;ARRB2;SLA2;ACTB;SPN;SLC9A3R1;CHSY1;ARHGDIA;UCP2;FLOT1;AKT1;E2F2;ITGB7;E2F4;CDIPT;CTSD;HRAS;RBM38;CD52;DAXX;LIMK2;LAPTM5;EMP3;DUSP7;CDC25B;MOB3A;GADD45G;TPST2;DOK2;FMNL1;IL2RB;PTPN6;TRIM37;PTPN7;ESYT1;LY6E;B4GALT5
Antigen processing: cross presentation	12/79	3.9207719844779875E-8	5.141812402501132E-6	0	0	9.28492814442377	158.34880588912884	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;TAP2;PSME2;CYBA;PSMB10;PSMB8;TAPBP;PSMB9
Immune system	46/998	5.2876420240258465E-8	6.067569222569659E-6	0	0	2.6285432540363085	44.042052705366615	ITGB1;PRKCSH;TRAC;WAS;PIK3CD;KEAP1;PSMB10;PYCARD;CDC42;PSMB4;PSMB2;PSMD3;RPS6KA1;AP2S1;AP1S1;AKT1;ITGB7;CSK;PRKACA;CTSD;HRAS;CTSA;VASP;NUP210;DTX3L;TAP2;EIF2AK2;CYBA;IRAK4;PSMB8;DDOST;PML;VAV1;DUSP7;PSMB9;TAPBP;SIGIRR;PSMC3;PSMC1;OAS3;NUP50;IL2RB;PSME2;PTPN6;TRIM37;MYD88
Integrin-mediated cell adhesion	13/100	7.195696073825788E-8	7.3396099953023035E-6	0	0	7.758987527512839	127.61360153897911	VASP;ITGB1;CDC42;CAPNS1;CAPN2;RAC2;ZYX;AKT1;ITGB7;CSK;CAPN1;TLN1;HRAS
DNA replication pre-Initiation	12/88	1.343554581438608E-7	1.1089287586234756E-5	0	0	8.181627809576993	129.4560713167412	CDT1;PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;RPA1;PSME2;E2F2;PSMB10;PSMB8;PSMB9
Cyclin A-Cdk2-associated events at S phase entry	11/72	1.3663028931368805E-7	1.1089287586234756E-5	0	0	9.326481047792523	147.41423984888155	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;CDC25A;PSMB10;PSMB8;CDC25B;PSMB9
ERBB1 downstream pathway	13/106	1.4495800766319942E-7	1.1089287586234756E-5	0	0	7.256177076183939	114.26172692377344	CYFIP2;ACTR2;ARPC1B;PIK3CD;ARPC4;ARPC5;RPS6KA4;CDC42;CAPN2;AKT1;CALM3;HRAS;YWHAH
Focal adhesion	19/233	1.6495888345889594E-7	1.1648635001174343E-5	0	0	4.654496084869916	72.69191648976364	VASP;ITGB1;PIK3CD;ACTB;VAV1;PPP1CA;CDC42;MYL6;CCND3;PARVG;RAC2;ZYX;CAPN2;AKT1;FLNA;ITGB7;CAPN1;TLN1;HRAS
Licensing factor removal from origins	10/61	2.5734667754812426E-7	1.6141321015584354E-5	0	0	10.119509545242899	153.54171662591284	CDT1;PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
S phase	13/112	2.786003346629325E-7	1.6141321015584354E-5	0	0	6.81431334622824	102.8517538191631	CDT1;RPA1;CDC25A;PSMB10;PSMB8;CDC25B;PSMB9;PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2
Fc gamma receptor-mediated phagocytosis	12/94	2.81330213779248E-7	1.6141321015584354E-5	0	0	7.580643074335253	114.34442429809566	CDC42;VASP;ARPC1B;LIMK2;CFL1;RAC2;WAS;PIK3CD;AKT1;ARPC4;ARPC5;VAV1
Apoptosis regulation	11/78	3.1681994820946164E-7	1.7089376856152565E-5	0	0	8.488667772249862	127.0323377747407	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;POMP;PSME2;CDC25A;PSMB10;PSMB8;PSMB9
Proteasome degradation	10/63	3.5233754659464745E-7	1.7089376856152565E-5	0	0	9.736645591676208	144.67366394218178	PSMB4;RPN2;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
Adaptive immune system	32/606	3.537016996371446E-7	1.7089376856152565E-5	0	0	2.9728183956509433	44.16065818560931	ITGB1;TRAC;WAS;PIK3CD;KEAP1;PSMB10;CDC42;PSMB4;PSMB2;PSMD3;AP2S1;AP1S1;AKT1;ITGB7;CSK;PRKACA;CTSD;HRAS;CTSA;VASP;DTX3L;TAP2;CYBA;PSMB8;VAV1;PSMB9;TAPBP;PSMC3;PSMC1;PSME2;PTPN6;TRIM37
Ubiquitin-mediated degradation of phosphorylated Cdc25A	10/64	4.1043100372967403E-7	1.883878307119204E-5	0	0	9.55584872471416	140.5288655924499	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;CDC25A;PSMB10;PSMB8;PSMB9
Hemostasis pathway	27/468	5.530038425881716E-7	2.4174167975997216E-5	0	0	3.242191904386064	46.71317961446355	ITGB1;DGKD;SELPLG;WDR1;ATP2A3;ARRB2;GNAI2;SPN;CDC42;CAPZB;CFL1;RAC2;AKT1;FLNA;CSK;PRKACA;HRAS;CAP1;VAV1;DOK2;MAFG;GNB2;PTPN6;CD48;PFN1;TLN1;F2RL3
HIV factor interactions with host	13/128	1.3117313557209853E-6	5.473497202508475E-5	0	0	5.861424606845514	79.38808822274197	NUP210;PSMB10;PSMB8;PSMB9;PSMB4;PSMB2;PSMC3;NUP50;PSMC1;PSMD3;AP2S1;AP1S1;PSME2
Autodegradation of Cdh1 by Cdh1-APC/C	9/58	1.6666976448411882E-6	6.652297556366133E-5	0	0	9.45531686358754	125.7998360796038	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
Platelet activation, signaling and aggregation	16/205	2.7832444081245046E-6	1.064590986107623E-4	0	0	4.408017362440955	56.386887577361094	CAP1;DGKD;WDR1;ARRB2;VAV1;GNAI2;CDC42;GNB2;CFL1;RAC2;AKT1;FLNA;CSK;PFN1;TLN1;F2RL3
Shigellosis	9/62	2.9648844616518758E-6	1.0887055743185688E-4	0	0	8.739920556107249	111.24758637943786	ITGB1;CDC42;ARPC1B;WAS;CSK;ARPC4;ARPC5;PFN1;ACTB
Downstream signaling events Of B cell receptor (BCR)	11/98	3.224632369683444E-6	1.0987868824304207E-4	0	0	6.530560116767013	82.57691870474787	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;AKT1;PSME2;HRAS;PSMB10;PSMB8;PSMB9
Cell cycle	25/453	3.2317261247953553E-6	1.0987868824304207E-4	0	0	3.0783031221115333	38.91742924250028	PSMB10;HDAC7;SYCE2;PSMB4;CCND3;PSMB2;RAD21;PSMD3;CEP250;E2F2;E2F4;PRKACA;YWHAH;CDKN2D;CDT1;RPA1;PSMB8;CDC25A;PSMB9;CDC25B;GADD45G;CDK6;PSMC3;PSMC1;PSME2
Destabilization of mRNA by AUF1 (hnRNP D0)	9/66	5.05161917092304E-6	1.5990987582439138E-4	0	0	8.124930747922438	99.09004453795505	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
Semaphorin interactions	9/66	5.05161917092304E-6	1.5990987582439138E-4	0	0	8.124930747922438	99.09004453795505	ITGB1;CDC42;SEMA4A;MYL6;SEMA4D;LIMK2;CFL1;RAC2;TLN1
Activation of NF-kappaB in B cells	9/68	6.499405526548228E-6	1.8833574709899866E-4	0	0	7.848706512042819	93.74337960392991	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
mRNA stability regulation by proteins that bind AU-rich elements	10/86	6.563646119677513E-6	1.8833574709899866E-4	0	0	6.7820441605332595	80.9366728825696	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;AKT1;PSME2;PSMB10;PSMB8;PSMB9
Neurotrophin signaling pathway	12/126	6.565080508897557E-6	1.8833574709899866E-4	0	0	5.443808460142399	64.96502627609988	RPS6KA4;CDC42;ARHGDIA;ARHGDIB;RPS6KA1;AKT1;PIK3CD;CALM3;CSK;IRAK4;HRAS;YWHAH
HIF-1 degradation in normoxia	10/88	8.08344977737702E-6	2.1348089945518814E-4	0	0	6.607469048102294	77.47714579403144	PSMB4;PSMB2;USP20;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
CDC42 signaling events	9/70	8.28865045350793E-6	2.1348089945518814E-4	0	0	7.590595340811044	88.81469742034949	CDC42;ACTR2;ARPC1B;ARHGDIA;LIMK2;CFL1;ARPC4;ARPC5;HRAS
Signaling by the B cell receptor (BCR)	13/151	8.299088590255843E-6	2.1348089945518814E-4	0	0	4.878758094357077	57.07837099782354	PIK3CD;VAV1;PSMB10;PSMB8;PSMB9;PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;AKT1;PSME2;HRAS
PDGFB signaling pathway	12/129	8.371799978634829E-6	2.1348089945518814E-4	0	0	5.3034074678637015	62.000236206185505	CYFIP2;SLC9A3R1;ACTR2;ARHGDIA;ARPC1B;EIF2AK2;PIK3CD;ARPC4;CSK;ARPC5;HRAS;YWHAH
G13 signaling pathway	7/39	8.97059528024588E-6	2.2256774235853292E-4	0	0	11.211796465968586	130.2985487506964	CDC42;ARHGDIB;CFL1;WAS;PIK3CD;CALM3;PFN1
Rac1 cell motility signaling pathway	9/71	9.330918098490474E-6	2.2541533722142778E-4	0	0	7.467784380305603	86.49320157416247	CYFIP2;ACTR2;ARPC1B;ARHGDIA;CFL1;CYBA;ARPC4;ARPC5;VAV1
Mammalian calpain regulation of cell motility	6/27	1.0908888260547796E-5	2.5677844674827893E-4	0	0	14.613950018649758	166.97800887209343	ITGB1;CAPNS1;CAPN2;CAPN1;TLN1;HRAS
Degradation of beta-catenin by the destruction complex	9/73	1.1754676035696803E-5	2.697698150192416E-4	0	0	7.233675986842106	82.11133280300261	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
Pathogenic Escherichia coli infection	8/57	1.3696282322972789E-5	3.066631017680249E-4	0	0	8.382666452407735	93.87233569317881	ITGB1;CDC42;ARPC1B;WAS;ARPC4;ARHGEF2;ARPC5;ACTB
CXCR4 signaling pathway	11/116	1.6560974658185425E-5	3.619755889574815E-4	0	0	5.4060468631897205	59.51225905561967	ITGB1;CDC42;CFL1;AKT1;PIK3CD;CSK;PTPN6;ARRB2;HRAS;VAV1;GNAI2
Cell cycle checkpoints	11/117	1.7965880449482047E-5	3.835506570377795E-4	0	0	5.354771887790756	58.51178588282068	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;RPA1;PSME2;CDC25A;PSMB10;PSMB8;PSMB9
EGF/EGFR signaling pathway	12/141	2.069023451975242E-5	4.316735292984709E-4	0	0	4.8071062858552835	51.84872123470207	MAP4K1;CDC42;NDUFA13;DOK2;LIMK2;CFL1;RPS6KA1;AP2S1;AKT1;CSK;EPN1;VAV1
Axon guidance	19/325	2.242146582267406E-5	4.573979027825508E-4	0	0	3.2396661367249604	34.68221913937721	VASP;CAP1;ITGB1;SEMA4A;SEMA4D;LIMK2;AGAP2;GNAI2;RPS6KA4;CDC42;MYL6;PPP3CC;RPS6KA1;CFL1;RAC2;AP2S1;PFN1;TLN1;HRAS
RhoA activity regulation	7/46	2.7770148854749104E-5	5.541955793186886E-4	0	0	9.196133709222714	96.48168646803286	ARHGAP9;ARHGDIA;ARHGDIB;ARHGEF2;DEF6;VAV1;ARHGAP4
APC/C-mediated degradation of cell cycle proteins	9/82	3.0427041449672178E-5	5.942983840595544E-4	0	0	6.338932948810382	65.9260362182541	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;PSMB10;PSMB8;PSMB9
HIV infection	14/200	3.9322810722909135E-5	7.520487550756372E-4	0	0	3.8989247311827957	39.54954533909255	NUP210;PSMB8;PSMB10;PSMB9;PSMB4;PSMB2;PSMC3;PSMC1;NUP50;PSMD3;AP2S1;AP1S1;PSME2;NELFCD
T cell receptor regulation of apoptosis	27/603	5.6023713636845034E-5	0.0010495871248698723	0	0	2.464822168508287	24.129957081918764	FKBP2;NDUFB7;EI24;TONSL;BZW1;GNAI2;PYCARD;SPN;CDC42;CCND3;ARHGDIB;RAC2;FLNA;E2F4;HRAS;CDKN2D;MAP4K1;ST14;SEMA4D;PSMB8;PSMB9;PSME2;NUCB1;CD2BP2;LCP1;PTPN7;PTMA
Carbohydrate metabolism	15/235	6.082888509116469E-5	0.0011095126559231812	0	0	3.535063198833252	34.31643439543437	PYGB;NUP210;CHPF;MDH2;B3GAT3;HEXB;GOT2;TALDO1;HK1;CHSY1;NUP50;PRKACA;B4GALT7;ARSB;B4GALT5
Salmonella infection	4/12	6.163959199573229E-5	0.0011095126559231812	0	0	25.45844155844156	246.79938114995804	CDC42;ACTR2;ARPC1B;ARPC4
Bacterial invasion of epithelial cells	8/71	6.960109936033382E-5	0.0012287271002458932	0	0	6.515185601799775	62.36811393860322	ITGB1;CDC42;ARPC1B;WAS;PIK3CD;ARPC4;ARPC5;ACTB
Leukocyte transendothelial migration	10/117	9.702656665449362E-5	0.0016805733620533045	0	0	4.809508544374029	44.44238747181551	VASP;ITGB1;CDC42;RAC2;PIK3CD;CYBA;THY1;ACTB;VAV1;GNAI2
Insulin signaling pathway	16/277	1.1353038233478255E-4	0.0019179659315515494	0	0	3.1801793473236573	28.886968516749246	CAP1;MAP4K1;PYGB;PIK3CD;PPP1CA;HK1;RPS6KA4;MYO1C;RPS6KA1;RAC2;FLOT1;AKT1;FLOT2;CALM3;PRKACA;HRAS
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	9/97	1.1491081289252202E-4	0.0019179659315515494	0	0	5.254395933014354	47.66448698612515	CTSA;CAPNS1;CTSZ;CAPN2;AKT1;CAPN1;PRKACA;CTSD;PPP1CA
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	15/255	1.513039971900835E-4	0.0024355641330635483	0	0	3.2371323529411766	28.474526787069088	DTX3L;TAP2;KEAP1;CYBA;PSMB8;PSMB10;PSMB9;TAPBP;PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;PSME2;TRIM37
MAPK signaling pathway	17/314	1.5305379897340732E-4	0.0024355641330635483	0	0	2.971814923427827	26.10656517724898	MAP4K1;DAXX;DUSP2;ARRB2;GADD45G;DUSP7;CDC25B;RPS6KA4;CDC42;PPP3CC;RPS6KA1;RAC2;AKT1;FLNA;PTPN7;PRKACA;HRAS
Cell cycle: G2/M checkpoint	5/27	1.5388095829813267E-4	0.0024355641330635483	0	0	11.593868371212121	101.78641092912223	CDKN2D;RPS6KA1;CDC25A;YWHAH;CDC25B
Mu-calpain pathway	4/15	1.6228556258793917E-4	0.0025250533297581043	0	0	18.512396694214875	161.5420067371224	ITGB1;CAPNS1;CAPN1;TLN1
PI3K subunit p85 role in regulation of actin organization and cell migration	4/16	2.1307108274629772E-4	0.0032462385770975805	0	0	16.96883116883117	143.4525426381887	CDC42;ACTR2;ARPC1B;ARPC4
DNA replication	13/207	2.1864964646883133E-4	0.0032462385770975805	0	0	3.4604765299407765	29.165034256932433	CDT1;RPA1;PSMB8;PSMB10;PSMB9;PSMB4;PSMB2;PSMC3;RAD21;PSMC1;PSMD3;PSME2;E2F2
Sema4D in semaphorin signaling	5/29	2.1924487122009802E-4	0.0032462385770975805	0	0	10.626627604166666	89.53275210637273	CDC42;MYL6;SEMA4D;LIMK2;RAC2
Developmental biology	20/420	2.3228212559334114E-4	0.003384682401502971	0	0	2.6031165311653117	21.78172820778499	ITGB1;VASP;CAP1;SEMA4A;SEMA4D;LIMK2;AGAP2;CDC42;RPS6KA4;MYL6;CCND3;RXRA;CFL1;RPS6KA1;AP2S1;RAC2;AKT1;PFN1;TLN1;HRAS
Antigen-activated B-cell receptor generation of second messengers	13/211	2.6353639092404154E-4	0.003780100107316721	0	0	3.3898694390715667	27.93699573284524	MAP4K1;PIK3CD;VAV1;CDC42;PPP3CC;RPS6KA1;SH3BP2;RAC2;AKT1;CALM3;CSK;PTPN6;HRAS
Chondroitin sulfate/dermatan sulfate metabolism	6/48	3.205671423959046E-4	0.004527394411068314	0	0	7.299142111152555	58.72465524441986	CHPF;CHSY1;B3GAT3;HEXB;B4GALT7;ARSB
Chemokine signaling pathway	12/189	3.4305316524720086E-4	0.004771557662074702	0	0	3.4948523130872635	27.880621610875814	CDC42;GNB2;RAC2;WAS;AKT1;PIK3CD;CSK;ARRB2;PRKACA;HRAS;VAV1;GNAI2
T cell receptor signaling pathway	10/139	3.97542457634019E-4	0.005446925016537752	0	0	3.984782475302203	31.201678875588208	CDC42;PPP3CC;AKT1;PIK3CD;CALM3;PTPN6;PTPN7;HRAS;VAV1;ARHGAP4
Lysosome	9/121	6.04273998090854E-4	0.008139408131876885	0	0	4.123378759398496	30.560350850765012	CTSA;ABCA2;HEXB;CTSZ;LAPTM5;AP1S1;MAN2B1;CTSD;ARSB
Non-small cell lung cancer	6/54	6.117855785397659E-4	0.008139408131876885	0	0	6.384791122715405	47.241891231327706	RXRA;CDK6;PIK3CD;AKT1;E2F2;HRAS
Prolactin activation of MAPK signaling	7/75	6.356959735839053E-4	0.008336698625000357	0	0	5.266438250692947	38.76514673741537	ITGB1;AGAP2;AKT1;FLNA;CTSD;HRAS;VAV1
Y branching of actin filaments	4/21	6.487997793380432E-4	0.008388707006089065	0	0	11.974942704354469	87.9007065111927	CDC42;ACTR2;ARPC1B;ARPC4
T cell receptor signaling in naive CD8+ T cells	6/55	6.756034573109369E-4	0.00855700998991088	0	0	6.254169552938669	45.65483893505608	PRF1;AKT1;CSK;PTPN6;HRAS;VAV1
Rho GTPase cycle	9/123	6.804594000691658E-4	0.00855700998991088	0	0	4.050623268698061	29.540152056295607	ARHGAP9;CDC42;ARHGAP30;ARHGDIA;ARHGDIB;RAC2;ARHGEF2;VAV1;ARHGAP4
Glycosaminoglycan biosynthesis: chondroitin sulfate	4/22	7.808947862535275E-4	0.00944961644646121	0	0	11.309090909090909	80.91733860524758	CHPF;CHSY1;B3GAT3;B4GALT7
Activation of Src by protein tyrosine phosphatase alpha	3/10	7.914637600456881E-4	0.00944961644646121	0	0	21.766099185788306	155.44535000931162	CSK;CDC25A;CDC25B
Cdc25 and Chk1 regulatory pathway in response to DNA damage	3/10	7.914637600456881E-4	0.00944961644646121	0	0	21.766099185788306	155.44535000931162	CDC25A;CDC25B;YWHAH
Cyclin D-associated events in G1	5/38	8.029085869542203E-4	0.00944961644646121	0	0	7.724905303030303	55.057483423690876	CDKN2D;CCND3;CDK6;E2F2;E2F4
RAC1 activity regulation	5/38	8.029085869542203E-4	0.00944961644646121	0	0	7.724905303030303	55.057483423690876	ARHGAP9;ARHGDIA;ARHGEF2;DEF6;VAV1
BAD phosphorylation mediated by IGF1R signaling	4/23	9.308994824119246E-4	0.01042153322992862	0	0	10.713328776486671	74.7721703357122	RPS6KA1;AKT1;HRAS;YWHAH
Collagen binding in corneal epithelia mediated by Erk and PI-3 Kinase	4/23	9.308994824119246E-4	0.01042153322992862	0	0	10.713328776486671	74.7721703357122	ITGB1;PFN1;TLN1;HRAS
Cyclins and cell cycle regulation	4/23	9.308994824119246E-4	0.01042153322992862	0	0	10.713328776486671	74.7721703357122	CDKN2D;CCND3;CDK6;CDC25A
Rho cell motility signaling pathway	4/23	9.308994824119246E-4	0.01042153322992862	0	0	10.713328776486671	74.7721703357122	CFL1;PFN1;TLN1;ARHGAP4
TGF-beta signaling pathway	11/185	0.001031045740042497	0.011403614329626655	0	0	3.250729793833242	22.355859482938243	ITGB1;MAP4K1;CDC42;DAXX;LIMK2;AKT1;ARRB2;E2F4;HRAS;PML;PPP1CA
Natural killer cell receptor signaling pathway	6/60	0.001075579478435349	0.011754547157186313	0	0	5.673629242819843	38.7786641885054	RAC2;AKT1;TSPO;PTPN6;HRAS;VAV1
Proteasome complex	4/24	0.0011000804901900643	0.011880869294052696	0	0	10.177142857142858	69.33048231696245	PSMB4;RPN2;PSMB2;PSMD3
DARPP-32 events	4/25	0.0012897039249061403	0.01376683957050973	0	0	9.692022263450834	64.48434463006653	PPP3CC;CALM3;PRKACA;PPP1CA
PI3K class IB pathway in neutrophils	5/43	0.0014222704469148714	0.014966191867105086	0	0	6.706757127192983	43.966151565040725	RAC2;AKT1;PRKACA;HRAS;VAV1
Progesterone-mediated oocyte maturation	7/86	0.0014346676299621434	0.014966191867105086	0	0	4.530585194512559	29.66093515662288	RPS6KA1;PIK3CD;AKT1;PRKACA;CDC25A;CDC25B;GNAI2
Natural killer cell-mediated cytotoxicity	9/137	0.001461852349221313	0.015078432096462532	0	0	3.604995888157895	23.533596706546266	PPP3CC;SH3BP2;PRF1;RAC2;PIK3CD;CD48;PTPN6;HRAS;VAV1
Ras signaling pathway	4/26	0.0015010320672530475	0.015227061150994764	0	0	9.251003541912633	60.14634648482483	CDC42;AKT1;HRAS;VAV1
MAPK cascade role in angiogenesis	6/64	0.00150943634503325	0.015227061150994764	0	0	5.281264067705051	34.30719161838616	CDC42;SEMA4A;DOK2;WAS;PIK3CD;AKT1
ERBB2/ERBB3 signaling events	5/44	0.0015793753729382374	0.015759419482144585	0	0	6.534455128205129	42.15197856995579	CDC42;PIK3CD;AKT1;PRKACA;HRAS
Glioma	6/65	0.0016361716528706064	0.016123617186707146	0	0	5.191485595433022	33.3054365668103	CDK6;PIK3CD;AKT1;E2F2;CALM3;HRAS
Disease	25/674	0.0016510021955887491	0.016123617186707146	0	0	2.006679760917049	12.855538606926196	ACTB;PSMB10;CDC42;PSMB4;PSMB2;PSMD3;AP2S1;AP1S1;AKT1;CSK;NELFCD;PRKACA;HRAS;NUP210;EIF2AK2;RAB27A;CYBA;PSMB8;EPN1;PSMB9;PSMC3;PSMC1;NUP50;PSME2;TLN1
Interleukin-3, interleukin-5, and GM-CSF signaling	5/45	0.0017488655093237122	0.016723526432907997	0	0	6.370768229166667	40.4466567672604	IL2RB;PIK3CD;PTPN6;HRAS;VAV1
RhoA signaling pathway	5/45	0.0017488655093237122	0.016723526432907997	0	0	6.370768229166667	40.4466567672604	ITGB1;CDC42;LIMK2;CFL1;TLN1
Alzheimer's disease	10/169	0.0017864047611654596	0.016906387327318473	0	0	3.2279583810424652	20.425068674419744	PPP3CC;NDUFB7;CAPN2;ATP2A3;CALM3;CAPN1;ATP5H;ATP5G3;SDHB;COX5A
Fas signaling pathway	8/115	0.0018482495296941988	0.01731319457407423	0	0	3.8274094242892533	24.087863552559952	DAXX;AKT1;PIK3CD;PTPN6;BAK1;ACTB;MYD88;PLEC
G1 to S cell cycle control	6/67	0.0019137276672360787	0.017729440595287433	0	0	5.020759320292771	31.42343780873925	CDKN2D;CCND3;CDK6;E2F2;E2F4;CDC25A
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	5/46	0.0019313116116870842	0.017729440595287433	0	0	6.215066056910569	38.84140284016569	ITGB1;RXRA;AKT1;HRAS;YWHAH
Interleukin receptor SHC signaling	4/28	0.0019938139871240263	0.018006042620142524	0	0	8.47922077922078	52.72130105017516	IL2RB;PIK3CD;PTPN6;HRAS
Endocytosis	11/201	0.0020006714022380583	0.018006042620142524	0	0	2.9745335561125037	18.484561940172338	CDC42;IL2RB;AGAP2;AP2S1;MVB12A;SNF8;ARRB2;VPS36;HRAS;EPN1;PML
NFAT involvement in hypertrophy of the heart	6/69	0.002225514876304777	0.01983517142182316	0	0	4.860872808653488	29.689078459236402	PPP3CC;ATP2A3;AKT1;CALM3;HRAS;YWHAH
S1P/S1P4 pathway	3/14	0.002265829659602083	0.0199140097528038	0	0	13.848327837965144	84.33374478083667	CDC42;S1PR4;GNAI2
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK)	4/29	0.0022777462135559904	0.0199140097528038	0	0	8.139636363636363	49.5261776872657	PPP3CC;AKT1;CALM3;YWHAH
Long-term potentiation	6/70	0.002395052361022589	0.020359586680842427	0	0	4.784676892950392	28.8724158975774	PPP3CC;RPS6KA1;CALM3;PRKACA;HRAS;PPP1CA
Pancreatic cancer	6/70	0.002395052361022589	0.020359586680842427	0	0	4.784676892950392	28.8724158975774	CDC42;CDK6;RAC2;PIK3CD;AKT1;E2F2
Cell surface interactions at the vascular wall	7/94	0.0023952454918638147	0.020359586680842427	0	0	4.112294638021304	24.814694321214937	ITGB1;SPN;DOK2;SELPLG;CD48;PTPN6;HRAS
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages	4/30	0.0025883348358738405	0.021492917456499023	0	0	7.826173826173826	46.61848682945803	AKT1;EIF2AK2;KREMEN2;MYD88
Interleukin-2/STAT5 pathway	4/30	0.0025883348358738405	0.021492917456499023	0	0	7.826173826173826	46.61848682945803	CCND3;CDK6;IL2RB;PRF1
Calcium regulation in the cardiac cell	9/149	0.0025988168166355026	0.021492917456499023	0	0	3.2939661654135337	19.607989125425593	RGS19;GNB2;ATP2A3;ANXA6;CALM3;ARRB2;PRKACA;YWHAH;GNAI2
Costimulation by the CD28 family	6/72	0.002763056681426827	0.02264719672812346	0	0	4.639211962971754	27.331535559924163	CDC42;TRAC;AKT1;CSK;PTPN6;VAV1
Signaling by Robo receptor	4/32	0.003294263813990366	0.025908966862949197	0	0	7.266419294990723	41.53174674050259	CDC42;CAP1;VASP;PFN1
Interleukin-2 receptor beta chain in T cell activation	5/52	0.0033304053003561213	0.025908966862949197	0	0	5.419991134751773	30.919213513291357	CCND3;IL2RB;AKT1;PTPN6;HRAS
Signaling events mediated by stem cell factor receptor (c-Kit)	5/52	0.0033304053003561213	0.025908966862949197	0	0	5.419991134751773	30.919213513291357	MAP4K1;AKT1;PTPN6;HRAS;VAV1
Myometrial relaxation and contraction pathways	9/155	0.0033841209067225855	0.025908966862949197	0	0	3.157624369142033	17.962654945377874	CNN2;RGS19;GNB2;ATP2A3;CALM3;ARRB2;PRKACA;ACTB;YWHAH
Cell-extracellular matrix interactions	3/16	0.003386793053980287	0.025908966862949197	0	0	11.71662016739737	66.64263352472763	ITGB1;VASP;FLNA
Inhibition of platelet activation by aspirin	3/16	0.003386793053980287	0.025908966862949197	0	0	11.71662016739737	66.64263352472763	ITGB1;HRAS;F2RL3
Other glycan degradation	3/16	0.003386793053980287	0.025908966862949197	0	0	11.71662016739737	66.64263352472763	MAN2B2;HEXB;MAN2B1
Rb tumor suppressor/checkpoint signaling in response to DNA damage	3/16	0.003386793053980287	0.025908966862949197	0	0	11.71662016739737	66.64263352472763	CDC25A;CDC25B;YWHAH
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	13/280	0.0034704661045200187	0.02632965193346593	0	0	2.5049007889074826	14.186421378101048	NUP210;EIF2AK2;PIK3CD;IRAK4;VAV1;PSMB8;PML;NUP50;OAS3;IL2RB;PTPN6;HRAS;MYD88
VEGF signaling pathway	6/76	0.0036241359780672354	0.027088362636095948	0	0	4.373218948153674	24.578099983989215	CDC42;PPP3CC;RAC2;PIK3CD;AKT1;HRAS
Cyclin B2-mediated events	2/5	0.0036294864969932477	0.027088362636095948	0	0	33.77777777777778	189.78598743166398	CDC25A;CDC25B
Glycoprotein VI-mediated activation cascade	4/33	0.0036919446189384356	0.027332299678915192	0	0	7.015494849977609	39.29800972123793	CDC42;RAC2;AKT1;VAV1
G alpha (12/13) signaling events	6/77	0.0038674343889295846	0.02840243815229887	0	0	4.311403670062148	23.950554200372988	CDC42;GNB2;RAC2;ARHGEF2;VAV1;ARHGAP4
Kit receptor signaling pathway	5/54	0.003926681735368418	0.028608681214827042	0	0	5.198235544217687	28.79801985447127	RPS6KA1;AKT1;PTPN6;HRAS;VAV1
Endocytotic role of NDK, phosphins and dynamin	3/17	0.004053743084911915	0.029301859464166437	0	0	10.879163582531458	59.923679832113926	PPP3CC;CALM3;EPN1
Signaling by NGF	11/221	0.004140906415587204	0.02969806319928948	0	0	2.6884731670445956	14.751223655442805	ARHGDIA;RPS6KA1;AP2S1;AKT1;ARHGEF2;PRKACA;HRAS;VAV1;MYD88;ARHGAP4;DUSP7
EGF receptor (ErbB1) signaling pathway	4/35	0.004582417739663473	0.0319606427817086	0	0	6.56221198156682	35.34097984260107	PIK3CD;PTPN6;TLN1;HRAS
MEF2D role in T cell apoptosis	4/35	0.004582417739663473	0.0319606427817086	0	0	6.56221198156682	35.34097984260107	PPP3CC;CAPNS1;CAPN2;CALM3
Signal transduction by L1	4/35	0.004582417739663473	0.0319606427817086	0	0	6.56221198156682	35.34097984260107	ITGB1;RPS6KA4;RPS6KA1;AP2S1
Thromboxane A2 receptor signaling	5/56	0.00459564798168359	0.0319606427817086	0	0	4.993872549019608	26.880245674726332	SLC9A3R1;AKT1;ARRB2;PRKACA;GNAI2
Pre-NOTCH processing in Golgi	3/18	0.004795019480757846	0.03284946181593808	0	0	10.153367875647668	54.220786759290625	LFNG;MFNG;ATP2A3
Transcriptional activity regulation by PML	3/18	0.004795019480757846	0.03284946181593808	0	0	10.153367875647668	54.220786759290625	DAXX;HRAS;PML
Respiratory electron transport, ATP biosynthesis by chemiosmotic coupling, and heat production by uncoupling proteins	6/81	0.004963000017437868	0.03366541579593561	0	0	4.080626631853786	21.650763854511254	NDUFA13;NDUFB7;UCP2;ATP5H;SDHB;COX5A
Amino acid metabolism	10/195	0.004987469006805276	0.03366541579593561	0	0	2.7705911716465805	14.686423687813724	PSMB4;PSMB2;PSMC3;PSMC1;PSMD3;GOT2;PSME2;PSMB8;PSMB10;PSMB9
PI3K/PLC/TRK pathway	4/36	0.005077405651240495	0.03402232399882317	0	0	6.3568181818181815	33.58278342143051	AGAP2;AKT1;HRAS;YWHAH
Signaling by interleukins	7/109	0.005449623728424842	0.03625184480213047	0	0	3.504850631352017	18.26801299971059	IL2RB;PIK3CD;PTPN6;IRAK4;HRAS;MYD88;VAV1
Response to elevated platelet cytosolic calcium	6/83	0.005589020231352802	0.036911658794114184	0	0	3.974229425926554	20.614134403249594	CAP1;WDR1;CFL1;FLNA;PFN1;TLN1
Glycosaminoglycan metabolism	7/110	0.005725397894040147	0.0375422519052061	0	0	3.470645046510446	17.918396284936478	CHPF;CHSY1;B3GAT3;HEXB;B4GALT7;ARSB;B4GALT5
Small cell lung cancer	6/84	0.0059227938199387644	0.038561168274494934	0	0	3.923076923076923	20.121253663897388	ITGB1;RXRA;CDK6;PIK3CD;AKT1;E2F2
Epidermal growth factor receptor (EGFR) pathway	7/111	0.00601148018468207	0.0385911804862807	0	0	3.437097261377366	17.577605051896484	RPS6KA4;RPS6KA1;RAC2;AKT1;HRAS;ACTB;VAV1
Signaling by EGFR in cancer	7/111	0.00601148018468207	0.0385911804862807	0	0	3.437097261377366	17.577605051896484	CDC42;AP2S1;AKT1;CSK;PRKACA;HRAS;EPN1
Trefoil factor initiation of mucosal healing	4/38	0.0061721656631327235	0.039076193646592	0	0	5.98227654698243	30.436061313118117	ITGB1;RPS6KA1;AKT1;HRAS
Triglyceride biosynthesis	4/38	0.0061721656631327235	0.039076193646592	0	0	5.98227654698243	30.436061313118117	ELOVL1;LPCAT4;GPD1L;AGPAT3
E-cadherin nascent AJ-like junctions pathway	4/39	0.006773962029389536	0.04259244618479174	0	0	5.8110575139146565	29.024309577100595	CYFIP2;CDC42;AKT1;ITGB7
Phospholipid metabolism	10/205	0.007026015433519329	0.04387674944197785	0	0	2.6271564846762736	13.025797905632412	CTSA;SLC44A2;LPCAT4;HEXB;PIK3CD;PIP4K2B;GPD1L;CDIPT;ARSB;AGPAT3
Androgen receptor signaling, proteolysis, and transcription regulation	6/88	0.007404304662462108	0.04545714958338982	0	0	3.7309431318856268	18.302864354287216	CDC42;DAXX;LIMK2;AKT1;FLNA;AES
BAD activation and translocation to mitochondria	2/7	0.00742763882081533	0.04545714958338982	0	0	20.264599483204133	99.34815668534279	PPP3CC;AKT1
Integrin alpha-2b beta-3 signaling	2/7	0.00742763882081533	0.04545714958338982	0	0	20.264599483204133	99.34815668534279	CSK;TLN1
E-cadherin keratinocyte pathway	3/21	0.007485972947305874	0.045510749441237036	0	0	8.459844559585493	41.40860659856056	VASP;ZYX;AKT1
Lipid and lipoprotein metabolism	18/489	0.007630349073068207	0.046083292428135615	0	0	1.9716036877435748	9.612793693513867	CTSA;ELOVL1;SLC44A2;HEXB;PIK3CD;AGPAT3;PPP1CA;HSD11B1;RXRA;LPCAT4;PIP4K2B;GPD1L;PRKACA;CDIPT;TEAD1;LBR;ABCD1;ARSB
Tricarboxylic acid (TCA) cycle and respiratory electron transport	7/117	0.007957383422304712	0.04761368411651487	0	0	3.2486197049024272	15.702707038738234	NDUFA13;NDUFB7;MDH2;UCP2;ATP5H;SDHB;COX5A
Alpha-M beta-2 integrin signaling	4/41	0.008091214294309717	0.04761368411651487	0	0	5.4963846963846965	26.475955703037343	SELPLG;AKT1;THY1;TLN1
ERBB1 internalization pathway	4/41	0.008091214294309717	0.04761368411651487	0	0	5.4963846963846965	26.475955703037343	CDC42;PIK3CD;HRAS;EPN1
Fc epsilon receptor I signaling in mast cells	4/41	0.008091214294309717	0.04761368411651487	0	0	5.4963846963846965	26.475955703037343	PPP3CC;CALM3;HRAS;VAV1
Thymic stromal lymphopoietin (TSLP) pathway	6/90	0.008237668503074828	0.04816674959122734	0	0	3.6417381574039536	17.47683952576449	PSMB4;PSMB2;PSME2;PSMB10;PSMB8;PSMB9
ERK1/ERK2 MAPK pathway	5/65	0.008626895568966784	0.05012335526779435	0	0	4.242838541666667	20.165662412915857	ITGB1;RPS6KA4;RPS6KA1;PRKACA;HRAS
Thyroid-stimulating hormone signaling pathway	5/66	0.00918886942358378	0.05305271780408748	0	0	4.173070355191257	19.57070833016952	CCND3;RPS6KA1;AKT1;HRAS;GNAI2
CREB transcription factor and its extracellular signals	3/23	0.009686742223347092	0.05472616302047057	0	0	7.613082901554404	35.30184340865021	RPS6KA1;AKT1;HRAS
Progesterone-initiated oocyte maturation	3/23	0.009686742223347092	0.05472616302047057	0	0	7.613082901554404	35.30184340865021	CAP1;RPS6KA1;HRAS
cAMP cell motility pathway inferred from amoeba model	5/67	0.009775575735789207	0.05472616302047057	0	0	4.105552755376344	18.99995735222797	CYFIP2;VASP;AKT1;PRKACA;ACTB
Lysosphingolipid and lysophosphatidic acid (LPA) G-protein coupled receptors	2/8	0.0097767872934174	0.05472616302047057	0	0	16.886304909560724	78.14550207863249	S1PR2;S1PR4
Visceral fat deposits and the metabolic syndrome	2/8	0.0097767872934174	0.05472616302047057	0	0	16.886304909560724	78.14550207863249	HSD11B1;RXRA
CD8/T cell receptor downstream pathway	5/68	0.010387513121400103	0.05779234572997148	0	0	4.040178571428571	18.452105019317276	IL2RB;PRF1;CALM3;PTPN7;HRAS
G-protein signaling pathways	6/95	0.010612636159313411	0.058689156591865736	0	0	3.436266025170886	15.620268480507502	PPP3CC;GNB2;CALM3;PRKACA;HRAS;GNAI2
Ras-independent pathway in NK cell-mediated cytotoxicity	3/24	0.01091341167431804	0.059633999506095006	0	0	7.25018504811251	32.754616428673046	ITGB1;PTPN6;VAV1
Signal transduction of S1P receptor	3/24	0.01091341167431804	0.059633999506095006	0	0	7.25018504811251	32.754616428673046	AKT1;S1PR2;GNAI2
Integrin-linked kinase signaling	4/45	0.011205314141123371	0.06015484433655704	0	0	4.959138422553057	22.273311335534643	CDC42;PARVG;ZYX;AKT1
Interleukin-3 signaling pathway	4/45	0.011205314141123371	0.06015484433655704	0	0	4.959138422553057	22.273311335534643	AKT1;PTPN6;PRKACA;HRAS
Wnt interactions in lipid metabolism and immune response	4/45	0.011205314141123371	0.06015484433655704	0	0	4.959138422553057	22.273311335534643	ITGB7;AXIN2;ARHGAP4;CDC25B
MicroRNA regulation of DNA damage response	5/70	0.011689027271008219	0.06202616783113032	0	0	3.9154647435897436	17.420312661167515	CCND3;CDK6;CDC25A;PML;GADD45G
Signaling events mediated by VEGFR1 and VEGFR2	5/70	0.011689027271008219	0.06202616783113032	0	0	3.9154647435897436	17.420312661167515	CDC42;AKT1;CALM3;PTPN6;PRKACA
Melanoma	5/71	0.012379551779507331	0.0650970062446054	0	0	3.855942234848485	16.934177055280742	CDK6;PIK3CD;AKT1;E2F2;HRAS
Alpha-4 beta-7 integrin signaling	2/9	0.012409560013949833	0.0650970062446054	0	0	14.473237356958288	63.52720899939468	ITGB1;ITGB7
LKB1 signaling events	4/47	0.01301518606802592	0.06754624462462337	0	0	4.727997583811537	20.52725607400159	PRKACA;CTSD;MARK2;YWHAH
Leishmaniasis	5/72	0.013097202116757037	0.06754624462462337	0	0	3.7981965174129355	16.466536531519253	ITGB1;CYBA;PTPN6;IRAK4;MYD88
Myocyte adrenergic pathway	5/72	0.013097202116757037	0.06754624462462337	0	0	3.7981965174129355	16.466536531519253	AKT1;ARRB2;PRKACA;HRAS;GNAI2
PGC-1a regulation	3/26	0.013624617470099165	0.06987373652263147	0	0	6.619058346474431	28.43466060769794	PPP3CC;CALM3;YWHAH
Chronic myeloid leukemia	5/73	0.013842425193984093	0.07059636848931887	0	0	3.7421492034313726	16.016462631449738	CDK6;PIK3CD;AKT1;E2F2;HRAS
Metabolism	44/1615	0.014520469248061784	0.07331788363389233	0	0	1.4645153553077057	6.198115959470651	NDUFA13;PIGT;DGKD;NDUFB7;ACAA2;RPN2;CHPF;HEXB;AK2;PIK3CD;ATP5H;ATP5G3;COX5A;AGPAT3;GNAI2;HK1;HSD11B1;CHSY1;AKT1;PIP4K2B;GGT1;CDIPT;LBR;XDH;ABCD1;ARSB;CTSA;ELOVL1;NUP210;MDH2;B3GAT3;GOT2;TALDO1;SDHB;DDOST;QARS;LPCAT4;GNB2;NUP50;CMPK2;GPD1L;SCLY;B4GALT7;B4GALT5
Adherens junction cell adhesion	5/74	0.014615656541396838	0.07331788363389233	0	0	3.6877264492753623	15.583085371872546	CDC42;RAC2;WAS;PTPN6;ACTB
Gastric acid secretion	5/74	0.014615656541396838	0.07331788363389233	0	0	3.6877264492753623	15.583085371872546	HRH2;CALM3;PRKACA;ACTB;GNAI2
BAD phosphorylation regulation	3/27	0.015110783308163825	0.07360386189672209	0	0	6.342940414507772	26.591805084553915	RPS6KA1;AKT1;YWHAH
EGFR downregulation	3/27	0.015110783308163825	0.07360386189672209	0	0	6.342940414507772	26.591805084553915	CDC42;AP2S1;EPN1
ERK5 role in neuronal survival pathway	3/27	0.015110783308163825	0.07360386189672209	0	0	6.342940414507772	26.591805084553915	RPS6KA1;AKT1;HRAS
Insulin regulation of blood glucose	3/27	0.015110783308163825	0.07360386189672209	0	0	6.342940414507772	26.591805084553915	AKT1;CALM3;YWHAH
VEGFR1 pathway	3/27	0.015110783308163825	0.07360386189672209	0	0	6.342940414507772	26.591805084553915	AKT1;CALM3;PRKACA
Deregulation of CDK5 in Alzheimer's disease	2/10	0.015314093270450893	0.07360386189672209	0	0	12.66343669250646	52.92027077676043	CAPNS1;CAPN1
Phospholipase C signaling pathway	2/10	0.015314093270450893	0.07360386189672209	0	0	12.66343669250646	52.92027077676043	AKT1;VAV1
TRAF6-mediated IRF7 activation in TLR7/8 or 9 signaling	2/10	0.015314093270450893	0.07360386189672209	0	0	12.66343669250646	52.92027077676043	IRAK4;MYD88
Protein processing in the endoplasmic reticulum	8/166	0.01615897548582481	0.07726010154159987	0	0	2.585202166184923	10.664681825391625	RPN2;PRKCSH;LMAN2;CAPN2;EIF2AK2;CAPN1;BAK1;DDOST
Phosphatidic acid biosynthesis	3/28	0.016684823360207563	0.07884335222548901	0	0	6.088911917098446	24.92347373768659	LPCAT4;GPD1L;AGPAT3
Recycling pathway of cell adhesion molecule L1	3/28	0.016684823360207563	0.07884335222548901	0	0	6.088911917098446	24.92347373768659	RPS6KA4;RPS6KA1;AP2S1
Electron transport chain	6/105	0.016747770897571193	0.07884335222548901	0	0	3.0875860431996203	12.626652588393275	NDUFB7;UCP2;ATP5H;ATP5G3;SDHB;COX5A
Mitochondrial pathway of apoptosis: caspases	5/77	0.017107578508930896	0.08012631158774777	0	0	3.5335286458333335	14.375220408749982	CAPNS1;CAPN2;AIP;CAPN1;PTMA
Phosphatidylinositol signaling system	5/78	0.01799696033656176	0.08274930580798472	0	0	3.484945776255708	14.00095228656269	DGKD;PIK3CD;PIP4K2B;CALM3;CDIPT
Messenger RNA processing	9/203	0.01819580692911182	0.08274930580798472	0	0	2.3704964731416167	9.497546068354964	SLBP;NUP210;HNRNPUL1;RBM8A;SNRPD1;NONO;NUP50;CD2BP2;PPM1G
Endometrial cancer	4/52	0.018322083199683554	0.08274930580798472	0	0	4.234415584415585	16.936172731352734	PIK3CD;AKT1;AXIN2;HRAS
Influence of Ras and Rho proteins on G1 to S transition	3/29	0.018347182189311858	0.08274930580798472	0	0	5.8544240733359905	23.40762244204777	CDK6;AKT1;HRAS
Reelin signaling pathway	3/29	0.018347182189311858	0.08274930580798472	0	0	5.8544240733359905	23.40762244204777	ITGB1;AKT1;ARHGEF2
S1P/S1P3 pathway	3/29	0.018347182189311858	0.08274930580798472	0	0	5.8544240733359905	23.40762244204777	AKT1;S1PR2;GNAI2
Capped intron-containing pre-mRNA processing	7/138	0.018467450478109854	0.08274930580798472	0	0	2.7249110746972542	10.877151602437495	SLBP;NUP210;HNRNPUL1;RBM8A;SNRPD1;NUP50;CD2BP2
CD28-dependent Vav1 pathway	2/11	0.018478875479996586	0.08274930580798472	0	0	11.255813953488373	44.92338371140678	CDC42;VAV1
Sonic Hedgehog (SHH) receptor PTCH1 regulation of cell cycle	2/11	0.018478875479996586	0.08274930580798472	0	0	11.255813953488373	44.92338371140678	CDC25A;CDC25B
Fc epsilon receptor I signaling pathway	5/79	0.01891634735958574	0.08348657151971013	0	0	3.4376759572072073	13.639765869885606	RAC2;PIK3CD;AKT1;HRAS;VAV1
Glycerophospholipid metabolism	5/79	0.01891634735958574	0.08348657151971013	0	0	3.4376759572072073	13.639765869885606	DGKD;LPCAT4;GPD1L;CDIPT;AGPAT3
p73 transcription factor network	5/79	0.01891634735958574	0.08348657151971013	0	0	3.4376759572072073	13.639765869885606	CDK6;FLOT2;BAK1;GRAMD4;PML
Androgen receptor regulation of biosynthesis and transcription	4/53	0.019522276259574763	0.08534023622042682	0	0	4.14778690697058	16.326515061744193	SMARCC1;RXRA;EHMT2;HDAC7
PI3K pathway	4/53	0.019522276259574763	0.08534023622042682	0	0	4.14778690697058	16.326515061744193	RPS6KA4;RPS6KA1;AKT1;HRAS
Opioid signaling	5/80	0.01986610107585884	0.0862155101591433	0	0	3.3916666666666666	13.291061404760898	PPP3CC;GNB2;PRKACA;GNAI2;PPP1CA
Apoptosis intrinsic pathway	3/30	0.020098169034920114	0.0862155101591433	0	0	5.637305699481865	22.025666830112485	PPP3CC;AKT1;BAK1
Retinoic acid receptor-mediated signaling	3/30	0.020098169034920114	0.0862155101591433	0	0	5.637305699481865	22.025666830112485	RXRA;AKT1;PRKACA
Signaling pathway from G-protein families	3/30	0.020098169034920114	0.0862155101591433	0	0	5.637305699481865	22.025666830112485	PPP3CC;CALM3;HRAS
Antigen processing and presentation	5/81	0.02084656985798145	0.08859792189642116	0	0	3.3468681469298245	12.954273585674832	TAP2;PSME2;PSMB8;TAPBP;PSMB9
MAP kinase signaling pathway	5/81	0.02084656985798145	0.08859792189642116	0	0	3.3468681469298245	12.954273585674832	RPS6KA4;MAP4K1;DAXX;RPS6KA1;HRAS
Regular glucocorticoid receptor pathway	5/82	0.0218580887694597	0.08884254408592979	0	0	3.303233225108225	12.628869176053781	SMARCC1;AKT1;PRKACA;YWHAH;FKBP5
Caspase-mediated cleavage of cytoskeletal proteins	2/12	0.021892738031269354	0.08884254408592979	0	0	10.129715762273902	38.71172473418616	DBNL;PLEC
D4-GDI signaling pathway	2/12	0.021892738031269354	0.08884254408592979	0	0	10.129715762273902	38.71172473418616	ARHGDIB;PRF1
Granzyme A-mediated apoptosis pathway	2/12	0.021892738031269354	0.08884254408592979	0	0	10.129715762273902	38.71172473418616	HMGB2;PRF1
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	2/12	0.021892738031269354	0.08884254408592979	0	0	10.129715762273902	38.71172473418616	PRKACA;PPP1CA
Rab GTPases mark targets in the endocytotic machinery	2/12	0.021892738031269354	0.08884254408592979	0	0	10.129715762273902	38.71172473418616	RAB27A;RAB8A
CD28 co-stimulation	3/31	0.02193796450697276	0.08884254408592979	0	0	5.435695780903035	20.761839002678258	CDC42;AKT1;VAV1
Gluconeogenesis	3/31	0.02193796450697276	0.08884254408592979	0	0	5.435695780903035	20.761839002678258	MDH2;GOT2;PRKACA
PD-1 signaling	3/31	0.02193796450697276	0.08884254408592979	0	0	5.435695780903035	20.761839002678258	TRAC;CSK;PTPN6
Prostaglandin biosynthesis and regulation	3/31	0.02193796450697276	0.08884254408592979	0	0	5.435695780903035	20.761839002678258	HSD11B1;ANXA5;ANXA6
Calcineurin-dependent NFAT signaling role in lymphocytes	4/55	0.022065468465786484	0.08884254408592979	0	0	3.9847211611917492	15.196696081072155	FKBP8;CALM3;PRKACA;YWHAH
Transport of mature transcript to cytoplasm	4/55	0.022065468465786484	0.08884254408592979	0	0	3.9847211611917492	15.196696081072155	SLBP;NUP210;RBM8A;NUP50
Oocyte meiosis	6/113	0.02314785501974815	0.0923901343831687	0	0	2.855567214074815	10.75364681236736	PPP3CC;RPS6KA1;CALM3;PRKACA;YWHAH;PPP1CA
mTOR signaling pathway	6/113	0.02314785501974815	0.0923901343831687	0	0	2.855567214074815	10.75364681236736	RPS6KA1;AKT1;PIK3CD;HRAS;PML;YWHAH
Acute myeloid leukemia	4/57	0.024801794301295223	0.0985629747557966	0	0	3.8339622641509434	14.173542286833339	PIK3CD;AKT1;HRAS;PML
Integrin cell surface interactions	5/85	0.02508209405798328	0.09924725148805454	0	0	3.1788736979166665	11.716060307421131	ITGB1;AKT1;ITGB7;CSK;TLN1
Advanced glycosylation endproduct receptor signaling	2/13	0.025544846371315016	0.09936512274943722	0	0	9.20836269673479	33.77000983277974	PRKCSH;DDOST
Chondroitin sulfate/dermatan sulfate degradation	2/13	0.025544846371315016	0.09936512274943722	0	0	9.20836269673479	33.77000983277974	HEXB;ARSB
Melanocyte development and pigmentation pathway	2/13	0.025544846371315016	0.09936512274943722	0	0	9.20836269673479	33.77000983277974	RPS6KA1;HRAS
PI3K class IB pathway	2/13	0.025544846371315016	0.09936512274943722	0	0	9.20836269673479	33.77000983277974	AKT1;HRAS
Syndecan 2 pathway	3/33	0.025884099156989103	0.10025992838023627	0	0	5.07279792746114	18.536644985719523	ITGB1;PRKACA;HRAS
Glycerophospholipid biosynthesis	5/86	0.026220892681989072	0.10113772891624356	0	0	3.1394675925925926	11.431425490715542	SLC44A2;LPCAT4;GPD1L;CDIPT;AGPAT3
p53 activity regulation	6/118	0.027885638852535213	0.1070625661353359	0	0	2.7273871689668034	9.763073639949061	CCND3;DAXX;CDK6;EI24;AKT1;GADD45G
EPO receptor signaling	3/34	0.027990213368715267	0.1070625661353359	0	0	4.908908574293832	17.553767900962427	AKT1;PTPN6;HRAS
Neurotrophic factor-mediated Trk receptor signaling	4/60	0.029274320278777723	0.11025251670423689	0	0	3.6280148423005567	12.810682175015772	CDC42;RGS19;GIPC1;HRAS
Integrated breast cancer pathway	7/152	0.029381917739816646	0.11025251670423689	0	0	2.460046939880845	8.677510132926104	CDC42;GRN;AKT1;BAK1;CDC25A;PML;CDC25B
MAP kinase inactivation of SMRT corepressor	2/14	0.02942469127727455	0.11025251670423689	0	0	8.440568475452196	29.76077863334572	RXRA;HRAS
T cell receptor/JNK pathway	2/14	0.02942469127727455	0.11025251670423689	0	0	8.440568475452196	29.76077863334572	MAP4K1;DBNL
T cell receptor/Ras pathway	2/14	0.02942469127727455	0.11025251670423689	0	0	8.440568475452196	29.76077863334572	PTPN7;HRAS
Integrated cancer pathway	3/35	0.030184698072875386	0.11128334470240805	0	0	4.755262305699482	16.645416085367174	AKT1;CDC25A;CDC25B
Interleukin-2/PI3K pathway	3/35	0.030184698072875386	0.11128334470240805	0	0	4.755262305699482	16.645416085367174	IL2RB;AKT1;CALM3
PIK3C1/AKT pathway	3/35	0.030184698072875386	0.11128334470240805	0	0	4.755262305699482	16.645416085367174	AKT1;PRKACA;YWHAH
fMLP induced chemokine gene expression in HMC-1 cells	3/35	0.030184698072875386	0.11128334470240805	0	0	4.755262305699482	16.645416085367174	PPP3CC;CALM3;HRAS
Glucose metabolism	4/61	0.030864377341656802	0.11333399359856378	0	0	3.564183185235817	12.396773001717703	PYGB;MDH2;GOT2;PRKACA
Generation of second messenger molecules	3/36	0.03246718306170553	0.11840884439470119	0	0	4.610927932171456	15.804072843642286	VASP;TRAC;WAS
Colorectal cancer	4/62	0.03250438865736895	0.11840884439470119	0	0	3.502552619793999	12.001076816856756	RAC2;PIK3CD;AKT1;AXIN2
ATR activation in response to replication stress	2/15	0.03352208037717508	0.11974034936282772	0	0	7.790896442059233	26.454385749243105	RPA1;CDC25A
Association of licensing factors with the pre-replicative complex	2/15	0.03352208037717508	0.11974034936282772	0	0	7.790896442059233	26.454385749243105	CDT1;E2F2
Cyclin A/B1-associated events during G2/M transition	2/15	0.03352208037717508	0.11974034936282772	0	0	7.790896442059233	26.454385749243105	CDC25A;CDC25B
Glycosylation of mammalian N-linked oligosaccarides	2/15	0.03352208037717508	0.11974034936282772	0	0	7.790896442059233	26.454385749243105	FUT7;MAN2B1
TrkA receptor signaling pathway	2/15	0.03352208037717508	0.11974034936282772	0	0	7.790896442059233	26.454385749243105	AKT1;HRAS
FSH regulation of apoptosis	10/263	0.033710564810615046	0.11994689339590935	0	0	2.0188346699761177	6.843736466160132	HSD11B1;ACTR2;PSMD3;RAB27A;PIK3CD;ARPC4;THY1;TLN1;YBX3;ACTB
p75 neurotrophin receptor-mediated signaling	6/124	0.03436471874166134	0.12180236218086915	0	0	2.5879098995441874	8.723132230944943	ARHGDIA;AKT1;ARHGEF2;MYD88;VAV1;ARHGAP4
Platelet aggregation (plug formation)	3/37	0.034837204894190996	0.12300213112641283	0	0	4.475083815909784	15.023166748996047	AKT1;CSK;TLN1
Endothelins	4/64	0.035934872022242555	0.12639161883685313	0	0	3.3854545454545453	11.26018123732706	CDC42;AKT1;HRAS;GNAI2
Toll receptor cascades	7/159	0.03619917603452613	0.12683528091486637	0	0	2.345911408101405	7.785420579135858	SIGIRR;RPS6KA1;EIF2AK2;IRAK4;PGLYRP1;MYD88;DUSP7
Glycosphingolipid metabolism	3/38	0.03729421208404875	0.1291927799741764	0	0	4.34700222057735	14.29693009514835	CTSA;HEXB;ARSB
Signaling of hepatocyte growth factor receptor	3/38	0.03729421208404875	0.1291927799741764	0	0	4.34700222057735	14.29693009514835	ITGB1;MAP4K1;HRAS
Transport of mature mRNAs derived from intronless transcripts	3/38	0.03729421208404875	0.1291927799741764	0	0	4.34700222057735	14.29693009514835	SLBP;NUP210;NUP50
B cell survival pathway	2/16	0.037827129834558965	0.13005732280196677	0	0	7.234034699150978	23.689501142345705	ITGB1;AKT1
Other semaphorin interactions	2/16	0.037827129834558965	0.13005732280196677	0	0	7.234034699150978	23.689501142345705	ITGB1;SEMA4A
Retinoblastoma protein regulation	4/66	0.039566640659308414	0.1355305079300191	0	0	3.2759111855886047	10.580436142834655	CCND3;CDK6;E2F2;E2F4
Interferon-gamma signaling pathway	5/97	0.04094255082087299	0.13972216228089743	0	0	2.7625396286231885	8.827931288587532	OAS3;AKT1;CALM3;PTPN6;PML
ABCA transporters in lipid homeostasis	2/17	0.04233025626074826	0.141821807472142	0	0	6.751421188630491	21.349703059718017	ABCA2;ABCD1
Activation of BH3-only proteins	2/17	0.04233025626074826	0.141821807472142	0	0	6.751421188630491	21.349703059718017	PPP3CC;AKT1
Cells and molecules involved in local acute inflammatory response	2/17	0.04233025626074826	0.141821807472142	0	0	6.751421188630491	21.349703059718017	ITGB1;SELPLG
Chromatin remodeling by hSWI/SNF ATP-dependent complexes	2/17	0.04233025626074826	0.141821807472142	0	0	6.751421188630491	21.349703059718017	SMARCC1;ACTB
G1/S-specific transcription	2/17	0.04233025626074826	0.141821807472142	0	0	6.751421188630491	21.349703059718017	CDT1;CDC25A
Insulin biosynthesis and processing	3/41	0.04518041325709362	0.15027398322468097	0	0	4.003204254158713	12.398290353029788	RPN2;RAB27A;DDOST
Plasma membrane estrogen receptor signaling	3/41	0.04518041325709362	0.15027398322468097	0	0	4.003204254158713	12.398290353029788	AKT1;HRAS;GNAI2
Tight junction	6/133	0.04578132994728795	0.15172296350761855	0	0	2.4034045352686007	7.411808568230963	CDC42;AKT1;YBX3;HRAS;ACTB;GNAI2
Interferon signaling	7/168	0.046395964770183484	0.1525312755343366	0	0	2.213749146369224	6.797411479569826	NUP210;NUP50;OAS3;EIF2AK2;PTPN6;PML;PSMB8
CBL signaling regulation	2/18	0.04702216881940877	0.1525312755343366	0	0	6.329134366925064	19.34902522745986	PIK3CD;VAV1
Corticosteroids and cardioprotection	2/18	0.04702216881940877	0.1525312755343366	0	0	6.329134366925064	19.34902522745986	AKT1;CALM3
Effect of METS on macrophage differentiation	2/18	0.04702216881940877	0.1525312755343366	0	0	6.329134366925064	19.34902522745986	E2F4;HRAS
Nicotinic acetylcholine receptor role in the regulation of apoptosis	2/18	0.04702216881940877	0.1525312755343366	0	0	6.329134366925064	19.34902522745986	AKT1;YWHAH
Tie2 signaling	2/18	0.04702216881940877	0.1525312755343366	0	0	6.329134366925064	19.34902522745986	DOK2;HRAS
Renal cell carcinoma	4/70	0.047434987169134954	0.15279059025005573	0	0	3.076741440377804	9.379123828123111	CDC42;PIK3CD;AKT1;HRAS
Signaling events mediated by HDAC class I	4/70	0.047434987169134954	0.15279059025005573	0	0	3.076741440377804	9.379123828123111	NUP210;PRKACA;MTA2;HDAC7
Hexose transport	3/42	0.047978256168401893	0.15293069153678104	0	0	3.9003587086488642	11.845418132888422	NUP210;NUP50;HK1
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	3/42	0.047978256168401893	0.15293069153678104	0	0	3.9003587086488642	11.845418132888422	ITGB1;PIK3CD;EIF2AK2
VEGF, hypoxia, and angiogenesis	3/42	0.047978256168401893	0.15293069153678104	0	0	3.9003587086488642	11.845418132888422	AKT1;CSK;HRAS
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	4/71	0.04952785131489114	0.15732376300024242	0	0	3.030664857530529	9.107814991102046	CAPNS1;CAPN2;CAPN1;BAK1
NGF signaling via TRKA from the plasma membrane	6/136	0.05005299163264745	0.15844360799575988	0	0	2.347579835308295	7.030233953135889	RPS6KA1;AP2S1;AKT1;PRKACA;HRAS;DUSP7
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model	3/43	0.05085917395644243	0.15932630393387728	0	0	3.8026554404145076	11.32694983687092	AKT1;PRKACA;HRAS
Growth hormone receptor signaling	3/43	0.05085917395644243	0.15932630393387728	0	0	3.8026554404145076	11.32694983687092	RPS6KA1;PTPN6;HRAS
Calcineurin in effects in keratinocyte differentiation	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	PPP3CC;CALM3
Glycosaminoglycan degradation	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	HEXB;ARSB
IGF-1 receptor and longevity	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	AKT1;HRAS
MAL role in Rho-mediated activation of SRF	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	CDC42;HRAS
PTEN-dependent cell cycle arrest and apoptosis	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	ITGB1;AKT1
Ras activation upon calcium influx through NMDA receptor	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	CALM3;HRAS
Small ligand GPCRs	2/19	0.05189386152094695	0.15932630393387728	0	0	5.956528347773218	17.622715361493842	S1PR2;S1PR4
Chagas disease	5/104	0.0524698670825907	0.1600243786771371	0	0	2.566287878787879	7.564175185113597	AKT1;PIK3CD;IRAK4;MYD88;GNAI2
Interleukin-4 signaling pathway	5/104	0.0524698670825907	0.1600243786771371	0	0	2.566287878787879	7.564175185113597	DOK2;AKT1;PIK3CD;PTPN6;THY1
Vasopressin-regulated water reabsorption	3/44	0.053822185009918706	0.16360518489769993	0	0	3.7097181852647543	10.840054496428207	ARHGDIA;ARHGDIB;PRKACA
Pathways in cancer	11/325	0.05402978207155967	0.16369419122670556	0	0	1.788385063862771	5.218900818927824	ITGB1;CDC42;RXRA;CDK6;RAC2;AKT1;PIK3CD;E2F2;AXIN2;HRAS;PML
E2F transcription factor network	4/74	0.056106539040701696	0.16887148471922675	0	0	2.9003339517625233	8.354420396161538	CCND3;E2F2;E2F4;CDC25A
RANKL regulation of apoptosis and immune response	4/74	0.056106539040701696	0.16887148471922675	0	0	2.9003339517625233	8.354420396161538	PYCARD;CDC42;MYL6;BAK1
G alpha (z) signaling events	3/45	0.05686625078020243	0.16915146935227462	0	0	3.6212065136935605	10.38219188945066	RGS19;GNB2;GNAI2
Apoptotic signaling in response to DNA damage	2/20	0.05693660569700747	0.16915146935227462	0	0	5.625322997416021	16.121145212364866	AKT1;TLN1
Chondroitin sulfate biosynthesis	2/20	0.05693660569700747	0.16915146935227462	0	0	5.625322997416021	16.121145212364866	CHPF;CHSY1
Estrogen receptor signaling pathway	2/20	0.05693660569700747	0.16915146935227462	0	0	5.625322997416021	16.121145212364866	AKT1;PRKACA
Toll-like receptor signaling pathway regulation	6/142	0.059308198560701804	0.1756287944474976	0	0	2.243318998617724	6.337393504937898	SIGIRR;AKT1;PIK3CD;PTPN6;IRAK4;MYD88
Gene expression	26/968	0.060797803898421106	0.17946104173231694	0	0	1.4195048340966117	3.974899722910592	SLBP;RPN2;RBM8A;EHMT2;PSMB10;PSMB4;RXRA;PSMB2;SNRPD1;PSMD3;EIF4H;AKT1;NELFCD;E2F4;TEAD1;NUP210;PSMB8;DDOST;PSMB9;QARS;PSMC3;HNRNPUL1;PSMC1;NUP50;PSME2;CD2BP2
Nicotine activity on dopaminergic neurons	2/21	0.06214194267610553	0.18167612540339134	0	0	5.328981368149055	14.80569072061275	PRKACA;PPP1CA
Oxidative stress-induced gene expression via Nrf2	2/21	0.06214194267610553	0.18167612540339134	0	0	5.328981368149055	14.80569072061275	MAFG;KEAP1
p38 MK2 pathway	2/21	0.06214194267610553	0.18167612540339134	0	0	5.328981368149055	14.80569072061275	CDC25B;YWHAH
ABC transporters	3/47	0.0631931303733655	0.18416283708809375	0	0	3.4562529439472445	9.544648775134391	ABCA2;TAP2;ABCD1
Signal transduction	27/1020	0.06536233631917339	0.18988172386392776	0	0	1.398424329421976	3.8146345886249837	ARHGAP9;ITGB1;DGKD;ATP2A3;ARRB2;ARHGAP4;HDAC7;GNAI2;LFNG;CDC42;HRH2;ARHGDIA;ARHGDIB;AP2S1;AKT1;ITGB7;CSK;E2F4;HRAS;EPN1;DUSP7;ARHGAP30;MFNG;GNB2;ARHGEF2;MYD88;F2RL3
Signaling by SCF-KIT	4/78	0.06557117911381856	0.18988751554096353	0	0	2.742997542997543	7.47362328390648	AKT1;PTPN6;HRAS;VAV1
Energy metabolism	3/48	0.06647361590927181	0.1912939793251145	0	0	3.3792746113989636	9.161045059579699	PPP3CC;RXRA;UCP2
Post-translational regulation of adherens junction stability and disassembly	3/48	0.06647361590927181	0.1912939793251145	0	0	3.3792746113989636	9.161045059579699	CDC42;PTPN6;HRAS
AKT signaling pathway	2/22	0.06750167661441805	0.19184687037781972	0	0	5.062273901808785	13.645879920140587	AKT1;YWHAH
CCR3 signaling in eosinophils	2/22	0.06750167661441805	0.19184687037781972	0	0	5.062273901808785	13.645879920140587	CFL1;HRAS
Nitric oxide signaling pathway	2/22	0.06750167661441805	0.19184687037781972	0	0	5.062273901808785	13.645879920140587	PPP3CC;CALM3
Smooth muscle contraction	2/22	0.06750167661441805	0.19184687037781972	0	0	5.062273901808785	13.645879920140587	MYL6;TLN1
Angiopoietin receptor Tie2-mediated signaling	3/49	0.06983050646291353	0.1972443228706296	0	0	3.3056431628745213	8.798578538940085	ITGB1;DOK2;AKT1
Ceramide signaling pathway	3/49	0.06983050646291353	0.1972443228706296	0	0	3.3056431628745213	8.798578538940085	AKT1;EIF2AK2;CTSD
Apoptosis modulation and signaling	4/80	0.07059593260512198	0.1987946813849754	0	0	2.67053998632946	7.07902132352092	DAXX;CAPNS1;BAK1;MYD88
Hypoxia and p53 in the cardiovascular system	2/23	0.07300786753475132	0.2038030460257145	0	0	4.820967146548542	12.617377697915115	RPA1;AKT1
Signaling events mediated by the hedgehog family	2/23	0.07300786753475132	0.2038030460257145	0	0	4.820967146548542	12.617377697915115	AKT1;ARRB2
Non-coding RNA metabolism	3/50	0.07326253288506077	0.2038030460257145	0	0	3.2351449674787784	8.455717645155701	NUP210;SNRPD1;NUP50
Translation factors	3/50	0.07326253288506077	0.2038030460257145	0	0	3.2351449674787784	8.455717645155701	EIF4H;EIF4EBP2;EIF2AK2
ATM-dependent DNA damage response	4/82	0.07581222846476227	0.21025868800801137	0	0	2.6017982017982018	6.711327206036403	CDC42;CCND3;RAC2;BAK1
Endogenous Toll-like receptor signaling	2/24	0.07865282448580545	0.21553221754617732	0	0	4.601597369039229	11.700535643960594	IRAK4;MYD88
Inhibition of cellular proliferation by Gleevec	2/24	0.07865282448580545	0.21553221754617732	0	0	4.601597369039229	11.700535643960594	AKT1;HRAS
Lysosome vesicle biogenesis	2/24	0.07865282448580545	0.21553221754617732	0	0	4.601597369039229	11.700535643960594	CTSZ;AP1S1
Plexin D1 signaling	2/24	0.07865282448580545	0.21553221754617732	0	0	4.601597369039229	11.700535643960594	ITGB1;SEMA4A
Apoptotic execution  phase	3/52	0.08034673816427321	0.2188673757709282	0	0	3.1027810087765677	7.823363773239932	DBNL;HMGB2;PLEC
Signaling events mediated by PTP1B	3/52	0.08034673816427321	0.2188673757709282	0	0	3.1027810087765677	7.823363773239932	AKT1;CSK;CAPN1
Transmembrane transport of small molecules	13/432	0.08082481996610032	0.21951829801443812	0	0	1.5836591682323669	3.9836490011071177	ABCA2;SLC14A1;NUP210;ATP8B2;SLC44A2;SLC35C1;ATP2A3;HK1;SLCO4A1;GNB2;NUP50;PRKACA;ABCD1
Cell junction organization	4/84	0.08121706971703514	0.2199329498532102	0	0	2.5364935064935064	6.368196275505446	ITGB1;VASP;FLNA;PLEC
Wnt signaling pathway	8/231	0.08279179955530813	0.22317919683821	0	0	1.82554759130445	4.548217210927553	CCND3;PPP3CC;RAC2;AKT1;KREMEN2;AXIN2;PRKACA;MARK2
Signaling by NOTCH	5/119	0.08290207638543531	0.22317919683821	0	0	2.226905153508772	5.545205767436334	LFNG;MFNG;ATP2A3;ARRB2;HDAC7
Asparagine N-linked glycosylation	4/85	0.0839891692831365	0.22335997935899962	0	0	2.505050505050505	6.205179005436831	RPN2;PRKCSH;DDOST;B4GALT5
MicroRNAs in cardiomyocyte hypertrophy	4/85	0.0839891692831365	0.22335997935899962	0	0	2.505050505050505	6.205179005436831	PIK3CD;AKT1;CALM3;HDAC7
Thrombin signaling through protease-activated receptors	3/53	0.08399620896559838	0.22335997935899962	0	0	3.0405699481865285	7.531441934376379	GNB2;ARRB2;F2RL3
Basigin interactions	2/25	0.08442909895160443	0.22335997935899962	0	0	4.4013032243568135	10.879331281185314	ITGB1;SPN
G0 and early G1 pathway	2/25	0.08442909895160443	0.22335997935899962	0	0	4.4013032243568135	10.879331281185314	E2F4;CDC25A
Phosphoinositides and their downstream targets	2/25	0.08442909895160443	0.22335997935899962	0	0	4.4013032243568135	10.879331281185314	AKT1;ARHGEF2
Notch signaling pathway	5/121	0.08754022364236921	0.23092507271176704	0	0	2.1882857399425286	5.329913245201779	LFNG;DTX3L;MFNG;AKT1;MARK2
Mitotic G2-G2/M phases	4/87	0.08967050775125794	0.2316269862526244	0	0	2.444437490220623	5.895038088546328	CEP250;PRKACA;CDC25A;CDC25B
ALK1 pathway	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	ARRB2;PPP1CA
ERBB2 role in signal transduction and oncology	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	AKT1;HRAS
Glycosaminoglycan biosynthesis: heparan sulfate	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	B3GAT3;B4GALT7
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	PPP3CC;CALM3
Integrin family cell surface interactions	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	ITGB1;ITGB7
Segmentation clock	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	LFNG;KREMEN2
Selenoamino acid metabolism	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	SCLY;GGT1
Tetrasaccharide linker sequence formation in glycosaminoglycan biosynthesis	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	B3GAT3;B4GALT7
YAP1- and WWTR1 (TAZ)-stimulated gene expression	2/26	0.09032947829895374	0.2316269862526244	0	0	4.217700258397933	10.140580557478795	RXRA;TEAD1
Activation of RAS in B cells	1/5	0.0935485276815601	0.236577268351714	0	0	12.633376288659793	29.931942160242087	HRAS
Axonal growth stimulation	1/5	0.0935485276815601	0.236577268351714	0	0	12.633376288659793	29.931942160242087	ARHGDIA
Flap intermediate removal from the telomere lagging strand (C-strand)	1/5	0.0935485276815601	0.236577268351714	0	0	12.633376288659793	29.931942160242087	RPA1
PKA-mediated phosphorylation of key metabolic factors	1/5	0.0935485276815601	0.236577268351714	0	0	12.633376288659793	29.931942160242087	PRKACA
Phenylalanine, tyrosine and tryptophan biosynthesis	1/5	0.0935485276815601	0.236577268351714	0	0	12.633376288659793	29.931942160242087	GOT2
Prostate cancer	4/89	0.09553153147638652	0.23969248564379964	0	0	2.3866768525592055	5.604630659651595	PIK3CD;AKT1;E2F2;HRAS
ADP signalling through P2Y purinoceptor 12	2/27	0.09634697952348809	0.23969248564379964	0	0	4.048785529715762	9.47334527950817	GNB2;GNAI2
Control of gene expression by vitamin D receptor	2/27	0.09634697952348809	0.23969248564379964	0	0	4.048785529715762	9.47334527950817	SMARCC1;RXRA
FSH signaling pathway	2/27	0.09634697952348809	0.23969248564379964	0	0	4.048785529715762	9.47334527950817	AKT1;PRKACA
Oxidative stress	2/27	0.09634697952348809	0.23969248564379964	0	0	4.048785529715762	9.47334527950817	CYBA;XDH
Rev-mediated nuclear export of HIV-1 RNA	2/27	0.09634697952348809	0.23969248564379964	0	0	4.048785529715762	9.47334527950817	NUP210;NUP50
Inositol phosphate metabolism	3/57	0.09927701302442375	0.24499004826994894	0	0	2.814766839378238	6.501664484122568	PIK3CD;PIP4K2B;CDIPT
Pre-NOTCH expression and processing	3/57	0.09927701302442375	0.24499004826994894	0	0	2.814766839378238	6.501664484122568	LFNG;MFNG;ATP2A3
SHP2 signaling	3/57	0.09927701302442375	0.24499004826994894	0	0	2.814766839378238	6.501664484122568	IL2RB;PRKACA;HRAS
Cell cycle: G1/S checkpoint	2/28	0.10247484306099139	0.24952760193631324	0	0	3.892864241701451	8.868481740167312	CDK6;CDC25A
Endosomal sorting complex required for transport (ESCRT) pathway	2/28	0.10247484306099139	0.24952760193631324	0	0	3.892864241701451	8.868481740167312	SNF8;VPS36
G-protein activation	2/28	0.10247484306099139	0.24952760193631324	0	0	3.892864241701451	8.868481740167312	GNB2;GNAI2
G-protein beta-gamma signalling	2/28	0.10247484306099139	0.24952760193631324	0	0	3.892864241701451	8.868481740167312	GNB2;AKT1
Nef in HIV-1 replication and disease pathogenesis	2/28	0.10247484306099139	0.24952760193631324	0	0	3.892864241701451	8.868481740167312	AP2S1;AP1S1
Caspase cascade in apoptosis	3/59	0.10730674748672474	0.25920153649994876	0	0	2.713961880088823	6.057735923313852	ARHGDIB;PRF1;AKT1
Cell-cell communication	5/129	0.10740293125735156	0.25920153649994876	0	0	2.0462659610215055	4.565562731431576	VASP;ITGB1;FLNA;PTPN6;PLEC
Amine compound SLC transporters	2/29	0.1087065267456212	0.25920153649994876	0	0	3.748492678725237	8.31829300941779	SLC14A1;SLC44A2
IGF1 pathway	2/29	0.1087065267456212	0.25920153649994876	0	0	3.748492678725237	8.31829300941779	AKT1;HRAS
Inhibition of insulin secretion by adrenaline/noradrenaline	2/29	0.1087065267456212	0.25920153649994876	0	0	3.748492678725237	8.31829300941779	GNB2;GNAI2
Phototransduction	2/29	0.1087065267456212	0.25920153649994876	0	0	3.748492678725237	8.31829300941779	CALM3;ARRB2
T cell receptor calcium pathway	2/29	0.1087065267456212	0.25920153649994876	0	0	3.748492678725237	8.31829300941779	CALM3;PRKACA
Thyroid cancer	2/29	0.1087065267456212	0.25920153649994876	0	0	3.748492678725237	8.31829300941779	RXRA;HRAS
L1CAM interactions	4/94	0.11094312896107822	0.26170859187342105	0	0	2.2535064935064937	4.95486937048373	ITGB1;RPS6KA4;RPS6KA1;AP2S1
Beta-oxidation of very long chain fatty acids	1/6	0.11118338870439455	0.26170859187342105	0	0	10.106185567010309	22.198987391304836	ABCD1
G beta-gamma signaling through PI3K gamma	1/6	0.11118338870439455	0.26170859187342105	0	0	10.106185567010309	22.198987391304836	AKT1
Influenza factor interactions with host	1/6	0.11118338870439455	0.26170859187342105	0	0	10.106185567010309	22.198987391304836	EIF2AK2
RSK activation	1/6	0.11118338870439455	0.26170859187342105	0	0	10.106185567010309	22.198987391304836	RPS6KA1
Parkinson's disease	5/131	0.11268661335510766	0.26456857048590493	0	0	2.013578869047619	4.395933927710811	NDUFB7;ATP5H;ATP5G3;SDHB;COX5A
Activation of the pre-replicative complex	2/30	0.11503570000545868	0.2665892013669527	0	0	3.614433370247324	7.816258297656293	CDT1;RPA1
CDC42 activity regulation	2/30	0.11503570000545868	0.2665892013669527	0	0	3.614433370247324	7.816258297656293	CDC42;ARHGDIA
Interferon-beta enhancer pathway	2/30	0.11503570000545868	0.2665892013669527	0	0	3.614433370247324	7.816258297656293	SMARCC1;ACTB
Nectin adhesion pathway	2/30	0.11503570000545868	0.2665892013669527	0	0	3.614433370247324	7.816258297656293	CDC42;TLN1
Nuclear events mediated by MAP kinases	2/30	0.11503570000545868	0.2665892013669527	0	0	3.614433370247324	7.816258297656293	RPS6KA1;DUSP7
Androgen receptor proteolysis and transcription regulation	3/61	0.11558006769504049	0.2665892013669527	0	0	2.6201089869572987	5.653649588631232	CCND3;CDK6;AKT1
Leptin signaling pathway	3/61	0.11558006769504049	0.2665892013669527	0	0	2.6201089869572987	5.653649588631232	CDC42;AKT1;HRAS
Membrane trafficking	5/133	0.11809317135456254	0.27170308597365517	0	0	1.9819132486979167	4.233924366651656	COPB2;CTSZ;AP1S1;SNF8;VPS36
Signaling events mediated by focal adhesion kinase	3/62	0.1198042571612184	0.2749507701849962	0	0	2.57556863089488	5.465088925938528	ITGB1;CAPN2;TLN1
Alpha-6 beta-4 integrin signaling pathway	2/31	0.12145623807660552	0.2753008063069725	0	0	3.4896195313196117	7.35682029815824	AKT1;HRAS
Keratan sulfate/keratin metabolism	2/31	0.12145623807660552	0.2753008063069725	0	0	3.4896195313196117	7.35682029815824	HEXB;B4GALT5
Ras family activation regulation	2/31	0.12145623807660552	0.2753008063069725	0	0	3.4896195313196117	7.35682029815824	CALM3;HRAS
Signal amplification	2/31	0.12145623807660552	0.2753008063069725	0	0	3.4896195313196117	7.35682029815824	GNB2;GNAI2
Transport of vitamins, nucleosides, and related molecules	2/31	0.12145623807660552	0.2753008063069725	0	0	3.4896195313196117	7.35682029815824	SLCO4A1;SLC35C1
Fatty acid, triacylglycerol, and ketone body metabolism	6/173	0.12215534927471319	0.2762034744684401	0	0	1.8239864917684214	3.8348617212302067	ELOVL1;RXRA;LPCAT4;GPD1L;TEAD1;AGPAT3
Oxidative phosphorylation	5/136	0.12642811422220654	0.2781627316688084	0	0	1.9362277353689568	4.004276564436809	NDUFB7;ATP5H;ATP5G3;SDHB;COX5A
Netrin-mediated signaling events	2/32	0.12796221650380782	0.2781627316688084	0	0	3.37312661498708	6.935216599922956	CDC42;AGAP2
Syndecan 4 pathway	2/32	0.12796221650380782	0.2781627316688084	0	0	3.37312661498708	6.935216599922956	ITGB1;GIPC1
Interferon alpha/beta signaling	3/64	0.12841998873704974	0.2781627316688084	0	0	2.4908689373991337	5.112382018448279	OAS3;PTPN6;PSMB8
Arachidonate epoxygenase/epoxide hydrolase pathway	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	COX5A
Attachment of GPI anchor to uPAR	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	PIGT
CREB phosphorylation	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	RPS6KA1
Caffeine metabolism	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	XDH
Cyanoamino acid metabolism	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	GGT1
Endothelial NOS activation	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	AKT1
FXR and LXR regulation of cholesterol metabolism	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	RXRA
Fas signaling pathway in cardiomyocytes	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	AKT1
Glucocorticoid biosynthesis	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	HSD11B1
Homologous DNA pairing and strand exchange	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	RPA1
MEK activation	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	HRAS
Nef-mediated CD8 downregulation	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	AP2S1
Negative regulation of the PI3K/Akt network	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	AKT1
Wnt/LRP6 signaling	1/7	0.12847603292764134	0.2781627316688084	0	0	8.42139175257732	17.28080456466185	KREMEN2
Dilated cardiomyopathy	4/100	0.13078694895009155	0.28249980973219774	0	0	2.112012987012987	4.296226455051587	ITGB1;ITGB7;PRKACA;ACTB
LPA receptor mediated events	3/65	0.13280843092609168	0.2861928159393243	0	0	2.450568276784222	4.947323781459103	AKT1;HRAS;GNAI2
GnRH signaling pathway	4/101	0.13422885068797688	0.2865776736393273	0	0	2.0901325478645068	4.197423191913497	CDC42;CALM3;PRKACA;HRAS
Melanogenesis	4/101	0.13422885068797688	0.2865776736393273	0	0	2.0901325478645068	4.197423191913497	CALM3;PRKACA;HRAS;GNAI2
E2F-mediated regulation of DNA replication	2/33	0.1345479055975491	0.2865776736393273	0	0	3.2641493706760025	6.547344948180729	CDT1;CDC25A
Glucagon signaling in metabolic regulation	2/33	0.1345479055975491	0.2865776736393273	0	0	3.2641493706760025	6.547344948180729	GNB2;PRKACA
PIP biosynthesis at the plasma membrane	2/33	0.1345479055975491	0.2865776736393273	0	0	3.2641493706760025	6.547344948180729	PIK3CD;PIP4K2B
p53 signaling pathway	5/139	0.1350254762700437	0.2869291370738428	0	0	1.892587842039801	3.7895131268062454	PYCARD;E2F2;BAK1;CTSD;PML
Endochondral ossification	3/66	0.1372485182529246	0.2903090777792276	0	0	2.411547002220577	4.789240694655114	AKT1;CALM3;PRKACA
HIF-1 transcriptional activity in hypoxia	3/66	0.1372485182529246	0.2903090777792276	0	0	2.411547002220577	4.789240694655114	AKT1;HK1;HDAC7
EGF receptor transactivation by GPCRs in cardiac hypertrophy	2/34	0.14120776522210077	0.2953119988858558	0	0	3.161983204134367	6.189654724213372	RPS6KA1;HRAS
MAPK/TRK pathway	2/34	0.14120776522210077	0.2953119988858558	0	0	3.161983204134367	6.189654724213372	RPS6KA1;HRAS
N-cadherin signaling events	2/34	0.14120776522210077	0.2953119988858558	0	0	3.161983204134367	6.189654724213372	CDC42;CALM3
TOR signaling	2/34	0.14120776522210077	0.2953119988858558	0	0	3.161983204134367	6.189654724213372	CDC42;AKT1
MHC class II antigen presentation	4/103	0.14122218683103563	0.2953119988858558	0	0	2.047697756788666	4.0082062544265495	CTSA;AP2S1;AP1S1;CTSD
Binding of RNA by insulin-like growth factor 2 mRNA binding proteins (IGF2BPs/IMPs/VICKZs)	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	ACTB
CHL1 interactions	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	ITGB1
Chromatin remodeling by nuclear receptors to facilitate initiation of transcription in carcinoma cells	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	RXRA
Cross-presentation of particulate exogenous antigens (phagosomes)	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	CYBA
Fatty acid elongation in mitochondria	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	ACAA2
Glucocorticoid and mineralcorticoid metabolism	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	HSD11B1
Mitotic metaphase/anaphase transition	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	RAD21
Proepithelin conversion to epithelin and wound repair control	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	GRN
Sema4D-mediated inhibition of cell attachment and migration	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	SEMA4D
Support of platelet aggregation by Eph kinases and ephrins	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	ITGB1
Transcription factor regulation of microRNAs related to cardiac hypertrophy	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	AKT1
Transport of nucleotide sugars	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	SLC35C1
Vitamin D biosynthesis	1/8	0.14543308392388815	0.2953707323940914	0	0	7.2179675994108985	13.916524493766076	RXRA
Messenger RNA splicing: major pathway	3/68	0.14627740258500413	0.29642970325173024	0	0	2.337106416899163	4.492503843630497	HNRNPUL1;RBM8A;CD2BP2
Fibroblast growth factor receptor pathway	4/105	0.14835708640152862	0.2999819500365711	0	0	2.006943551498007	3.8295155514178787	RPS6KA4;RPS6KA1;AKT1;HRAS
Interleukin-5 regulation of apoptosis	5/144	0.1499123605880703	0.3022660158549868	0	0	1.8240407673860912	3.461490223573956	CCND3;PSMB4;LIMK2;ZYX;MYD88
Huntington's disease	6/184	0.1501452104900588	0.3022660158549868	0	0	1.7103001144131194	3.242989637982399	NDUFB7;AP2S1;ATP5H;ATP5G3;SDHB;COX5A
GM-CSF-mediated signaling events	2/36	0.1547287521888503	0.3087847706725317	0	0	2.9756801945584437	5.552862299447092	PRKACA;HRAS
Glycogen metabolism	2/36	0.1547287521888503	0.3087847706725317	0	0	2.9756801945584437	5.552862299447092	PYGB;CALM3
Ion transport by P-type ATPases	2/36	0.1547287521888503	0.3087847706725317	0	0	2.9756801945584437	5.552862299447092	ATP8B2;ATP2A3
Phospholipids as signaling intermediaries	2/36	0.1547287521888503	0.3087847706725317	0	0	2.9756801945584437	5.552862299447092	AKT1;HRAS
Antiviral mechanism by interferon-stimulated genes	3/70	0.1554941989779573	0.30963920750925117	0	0	2.2671100456267883	4.2194247283344914	NUP210;NUP50;EIF2AK2
Interleukin-6 signaling pathway	3/71	0.1601691865874301	0.31123856178846016	0	0	2.2336558975921976	4.090995738330078	AKT1;HRAS;VAV1
Viral myocarditis	3/71	0.1601691865874301	0.31123856178846016	0	0	2.2336558975921976	4.090995738330078	PRF1;RAC2;ACTB
Activation of NMDA receptor upon glutamate binding and postsynaptic events	2/37	0.16157970090656743	0.31123856178846016	0	0	2.890513104466593	5.268702283654631	RPS6KA1;HRAS
AKT phosphorylation of nuclear targets	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	AKT1
Abl role in Robo-Slit signaling	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	CAP1
Axonogenesis regulation by p75 neurotrophin receptor	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	ARHGDIA
Calcium/calmodulin-dependent protein kinase activation	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	CALM3
EGFR transactivation by gastrin	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	HRAS
Folding of actin by CCT/TriC	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	ACTB
Inactivation of Cdc42 and Rac	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	CDC42
Inhibition of matrix metalloproteinases	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	HRAS
MAP kinase pathway regulation through dual specificity phosphatases	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	DUSP2
Nef-mediated CD4 downregulation	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	AP2S1
Nitric oxide effects	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	XDH
PI3K/AKT signalling	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	AKT1
PPAR-gamma coactivator role in obesity and thermogenesis	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	RXRA
Type I hemidesmosome assembly	1/9	0.1620610376196993	0.31123856178846016	0	0	6.315399484536083	11.492651815926612	PLEC
Sphingolipid metabolism	3/72	0.16488650790179105	0.31600378758631353	0	0	2.201171435007885	3.967606828926441	CTSA;HEXB;ARSB
Signaling events mediated by HDAC class II	2/38	0.16848445324186845	0.3222265168250734	0	0	2.810077519379845	5.004500210574333	NUP210;HDAC7
EGFR1 pathway	5/152	0.1750788260618935	0.3281367351727103	0	0	1.72406462585034	3.004215319212899	CDC42;GRN;COTL1;ZYX;CORO1A
Angiotensin II-mediated activation of JNK pathway via Pyk2-dependent signaling	2/39	0.17543834154532315	0.3281367351727103	0	0	2.7339898037572454	4.7584207488123775	CALM3;HRAS
FAS pathway and stress induction of heat shock protein regulation	2/39	0.17543834154532315	0.3281367351727103	0	0	2.7339898037572454	4.7584207488123775	DAXX;ARHGDIB
GAB1 signalosome	2/39	0.17543834154532315	0.3281367351727103	0	0	2.7339898037572454	4.7584207488123775	AKT1;CSK
Signaling events regulated by Ret tyrosine kinase	2/39	0.17543834154532315	0.3281367351727103	0	0	2.7339898037572454	4.7584207488123775	PRKACA;HRAS
Tricarboxylic acid (TCA) cycle	2/39	0.17543834154532315	0.3281367351727103	0	0	2.7339898037572454	4.7584207488123775	MDH2;SDHB
Apoptotic DNA fragmentation and tissue homeostasis	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	HMGB2
COPI-mediated vesicle transport	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	COPB2
E2F-enabled inhibition of pre-replication complex formation	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	CDC25A
Electron transport reaction in mitochondria	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	SDHB
Free radical-induced apoptosis	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	XDH
Glycoprotein 1b-IX-V activation signaling	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	FLNA
Nef-mediated downregulation of MHC class I complex cell surface expression	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	AP1S1
Purine catabolism	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	XDH
Reduction of cytosolic calcium levels	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	ATP2A3
Signal-dependent regulation of myogenesis by corepressor MITR	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	YWHAH
Splicing regulation through Sam68	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	HRAS
Taurine and hypotaurine metabolism	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	GGT1
Tetrahydrobiopterin (BH4) biosynthesis, recycling, salvage and regulation	1/10	0.17836626454377172	0.3281367351727103	0	0	5.61340206185567	9.677034621365255	AKT1
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3/75	0.17927714274168452	0.32849584238895485	0	0	2.1091321243523318	3.625223512527016	ITGB1;ITGB7;ACTB
Glycolysis and gluconeogenesis	3/75	0.17927714274168452	0.32849584238895485	0	0	2.1091321243523318	3.625223512527016	MDH2;GOT2;HK1
Phagosome	5/154	0.18160982316173882	0.33210720649895664	0	0	1.7007480425055927	2.901297109123951	ITGB1;TAP2;CYBA;CORO1A;ACTB
Pyruvate metabolism and citric acid (TCA) cycle	2/40	0.18243685856537872	0.3329563343201146	0	0	2.661906704746362	4.528838023432782	MDH2;SDHB
Post-translational protein modification	6/196	0.1836190948580495	0.33444906563430443	0	0	1.6012917411021026	2.7140162473405613	PIGT;RPN2;PRKCSH;ARSB;DDOST;B4GALT5
Bioactive peptide-induced signaling pathway	2/41	0.18947565294872842	0.344432969122639	0	0	2.5935201749155237	4.31430717734377	CALM3;HRAS
Vascular smooth muscle contraction	4/116	0.18988038868946136	0.34448655497416114	0	0	1.8088126159554732	3.0050906248060834	MYL6;CALM3;PRKACA;PPP1CA
Jak-STAT signaling pathway	6/199	0.1924182206597972	0.345102323874965	0	0	1.5761576861158837	2.5976403321499513	CCND3;IL2RB;AKT1;PIK3CD;PTPN6;PTPN7
Alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	ABCD1
CDC6 association with the ORC-origin complex	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	E2F2
Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	SLC9A3R1
Glutathione biosynthesis and recycling	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	GGT1
Keratan sulfate degradation	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	HEXB
Mechanism of protein import into the nucleus	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	NUP210
Monocyte and its surface molecules	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	ITGB1
SLBP-dependent processing of replication-dependent histone pre-mRNAs	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	SLBP
Transport of organic anions	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	SLCO4A1
eIF2 regulation	1/11	0.19435501246553039	0.345102323874965	0	0	5.0518041237113405	8.275202875850301	EIF2AK2
Aldosterone-regulated sodium reabsorption	2/42	0.19655052488867172	0.34698727278423197	0	0	2.5285529715762274	4.113540386638083	HSD11B1;PIK3CD
Bladder cancer	2/42	0.19655052488867172	0.34698727278423197	0	0	2.5285529715762274	4.113540386638083	E2F2;HRAS
Netrin-1 signaling	2/42	0.19655052488867172	0.34698727278423197	0	0	2.5285529715762274	4.113540386638083	CDC42;AGAP2
Signaling events mediated by hepatocyte growth factor receptor (c-Met)	3/79	0.19896504320298244	0.3505756423422992	0	0	1.9977161167166622	3.225564646337607	CDC42;AKT1;HRAS
Cleavage of growing transcript in the termination region	2/43	0.20365742197277575	0.35664988601238795	0	0	2.4667549001071407	3.9253865426035657	SLBP;RBM8A
G2/M checkpoints	2/43	0.20365742197277575	0.35664988601238795	0	0	2.4667549001071407	3.9253865426035657	RPA1;CDC25A
Insulin secretion regulation by glucagon-like peptide-1	2/43	0.20365742197277575	0.35664988601238795	0	0	2.4667549001071407	3.9253865426035657	GNB2;PRKACA
Nuclear beta-catenin signaling and target gene transcription regulation	3/80	0.20396643807898002	0.35664988601238795	0	0	1.9716708162304017	3.1345619045887814	AXIN2;YWHAH;AES
Alanine and aspartate metabolism	1/12	0.21003340842243678	0.3637358182635475	0	0	4.5923149015932525	7.166255387666596	GOT2
ERK inactivation	1/12	0.21003340842243678	0.3637358182635475	0	0	4.5923149015932525	7.166255387666596	DUSP7
Phospholipase C epsilon pathway	1/12	0.21003340842243678	0.3637358182635475	0	0	4.5923149015932525	7.166255387666596	RAP2B
Platelet endothelial cell adhesion molecule 1 (PECAM1) interactions	1/12	0.21003340842243678	0.3637358182635475	0	0	4.5923149015932525	7.166255387666596	PTPN6
G-protein-mediated events	2/44	0.21079243498497524	0.3637358182635475	0	0	2.4078995939461056	3.7488139707929204	PRKACA;GNAI2
Gastrin pathway	2/44	0.21079243498497524	0.3637358182635475	0	0	2.4078995939461056	3.7488139707929204	ITGB1;HDAC7
Interactions of HIV Vpr protein with host cellular proteins	2/44	0.21079243498497524	0.3637358182635475	0	0	2.4078995939461056	3.7488139707929204	NUP210;NUP50
Gastrin-CREB signaling pathway via PKC and MAPK	6/206	0.2135487836387211	0.36780071928770347	0	0	1.520443864229765	2.347398043517354	DGKD;RGS19;GNB2;RPS6KA1;HRAS;F2RL3
Platelet homeostasis	3/82	0.21405431236855568	0.3679810089032474	0	0	1.921558339345445	2.962131179927673	GNB2;ATP2A3;PTPN6
Amino sugar and nucleotide sugar metabolism	2/45	0.21795179391710015	0.37293419041744913	0	0	2.3517817438855837	3.5828956718605864	HEXB;HK1
HNF3B pathway	2/45	0.21795179391710015	0.37293419041744913	0	0	2.3517817438855837	3.5828956718605864	UCP2;AKT1
SLC-mediated transmembrane transport	7/251	0.218154314002364	0.37293419041744913	0	0	1.4544781563814264	2.2145195047699033	SLC14A1;NUP210;SLC44A2;SLCO4A1;NUP50;SLC35C1;HK1
Meiosis	3/83	0.21913792675302132	0.37322563406173204	0	0	1.8974417098445595	2.8804188728147055	SYCE2;RAD21;RPA1
T cell signal transduction	3/83	0.21913792675302132	0.37322563406173204	0	0	1.8974417098445595	2.8804188728147055	CSK;HRAS;VAV1
Differentiation pathway in PC12 cells	3/84	0.22424610728027602	0.3741845378246034	0	0	1.8739205526770293	2.801532096167656	AKT1;PRKACA;HRAS
Activation of DNA fragmentation factor	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	HMGB2
Adenylate cyclase inhibitory pathway	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	GNAI2
Arylsulfatase activation	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	ARSB
CTL mediated immune response against target cells	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	PRF1
Chemiosmotic coupling formation of ATP	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	ATP5H
Double stranded RNA-induced gene expression	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	EIF2AK2
Downregulation of ERBB2-ERBB3 signaling	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	AKT1
Keap1-Nrf2 pathway	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	KEAP1
MAP kinase downregulation by phosphorylation of MEK1 by Cdk5/p35	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	HRAS
N-glycan trimming in the ER and calnexin/calreticulin cycle	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	PRKCSH
Platelet adhesion to exposed collagen	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	ITGB1
Signal regulatory protein (SIRP) family interactions	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	PTPN6
T helper cell surface molecules	1/13	0.2254074612385683	0.3741845378246034	0	0	4.209407216494846	6.271366717866696	THY1
Factors involved in megakaryocyte development and platelet production	4/125	0.22625073202265644	0.3742309405347723	0	0	1.6735000536653428	2.487007609649294	CDC42;CAPZB;MAFG;PRKACA
Integration of energy metabolism	4/125	0.22625073202265644	0.3742309405347723	0	0	1.6735000536653428	2.487007609649294	GNB2;TALDO1;PRKACA;GNAI2
Actions of nitric oxide in the heart	2/47	0.23232914233224095	0.3829051214739626	0	0	2.2470284237726097	3.2797631272944674	AKT1;CALM3
Agrin in postsynaptic differentiation	2/47	0.23232914233224095	0.3829051214739626	0	0	2.2470284237726097	3.2797631272944674	ITGB1;CDC42
ATM pathway	2/48	0.23954025318356625	0.3859500916764265	0	0	2.1980676328502415	3.1411129519334207	RPA1;CDC25A
Lipid digestion, mobilization, and transport	2/48	0.23954025318356625	0.3859500916764265	0	0	2.1980676328502415	3.1411129519334207	PRKACA;PPP1CA
N-glycan biosynthesis	2/48	0.23954025318356625	0.3859500916764265	0	0	2.1980676328502415	3.1411129519334207	RPN2;DDOST
Presenilin action in Notch and Wnt signaling	2/48	0.23954025318356625	0.3859500916764265	0	0	2.1980676328502415	3.1411129519334207	KREMEN2;AES
AKT phosphorylation of cytosolic targets	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	AKT1
Adhesion and diapedesis of lymphocytes	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	ITGB1
CARM1 transcriptional regulation by protein methylation	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	RXRA
DCC-mediated attractive signaling	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	CDC42
Glycogen breakdown (glycogenolysis)	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	PYGB
Glycosphingolipid biosynthesis: globo series	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	HEXB
HIV-1 early elongation complex formation	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	NELFCD
Hyaluronan metabolism	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	HEXB
Interferon gamma signaling regulation	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	PTPN6
Retrograde neurotrophin signaling	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	AP2S1
Sema3A-plexin repulsion signaling by inhibiting integrin adhesion	1/14	0.24048306365894986	0.3859500916764265	0	0	3.8854084060269627	5.537117329363008	TLN1
FoxO family signaling	2/49	0.24676194537209367	0.39196111853568927	0	0	2.1511902798394633	3.010227656379384	AKT1;YWHAH
G alpha 12 pathway	2/49	0.24676194537209367	0.39196111853568927	0	0	2.1511902798394633	3.010227656379384	HRAS;VAV1
Glycerolipid metabolism	2/49	0.24676194537209367	0.39196111853568927	0	0	2.1511902798394633	3.010227656379384	DGKD;AGPAT3
Interleukin-5 signaling pathway	2/49	0.24676194537209367	0.39196111853568927	0	0	2.1511902798394633	3.010227656379384	RPS6KA1;AKT1
Muscle contraction	2/49	0.24676194537209367	0.39196111853568927	0	0	2.1511902798394633	3.010227656379384	MYL6;TLN1
BDNF signaling pathway	7/261	0.2467903338928414	0.39196111853568927	0	0	1.3964937956053922	1.9539966770290995	PSMB4;WDR1;ARPC1B;TWF2;ZYX;EMP3;CLIC1
Aquaporin-mediated transport	2/50	0.253991088219254	0.39594041372622596	0	0	2.106266149870801	2.886545289796675	GNB2;PRKACA
Phosphatidylinositol metabolism	2/50	0.253991088219254	0.39594041372622596	0	0	2.106266149870801	2.886545289796675	PIK3CD;PIP4K2B
Type 2 diabetes mellitus	2/50	0.253991088219254	0.39594041372622596	0	0	2.106266149870801	2.886545289796675	PIK3CD;HK1
Type II interferon signaling (interferon-gamma)	2/50	0.253991088219254	0.39594041372622596	0	0	2.106266149870801	2.886545289796675	EIF2AK2;PSMB9
Adhesion and diapedesis of granulocytes	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	SELPLG
Calcium signaling by HBx of hepatitis B virus	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	HRAS
Glycosphingolipid biosynthesis: ganglio series	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	HEXB
Lagging strand processive biosynthesis	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	RPA1
Mechanisms of transcriptional repression by DNA methylation	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	MTA2
Sema3A/PAK-dependent axon repulsion	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	CFL1
Signaling to p38 via RIT and RIN	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	HRAS
Spliceosomal assembly	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	SNRPD1
Stress induction of HSP regulation	1/15	0.25526599469925926	0.39594041372622596	0	0	3.607695139911635	4.926124302022597	DAXX
Gap junction pathway	3/90	0.255334123012991	0.39594041372622596	0	0	1.7441486510630695	2.3810808760248645	PRKACA;HRAS;GNAI2
Cell adhesion molecules (CAMs)	4/133	0.2599288382214377	0.40238562139507555	0	0	1.5690727876774389	2.1140861166887257	ITGB1;SPN;SELPLG;ITGB7
Neural crest differentiation	3/91	0.26057614307292193	0.4027085847490611	0	0	1.724240461610928	2.3188623110697906	ITGB1;AXIN2;HDAC7
Type I interferon (interferon-alpha/beta) pathway	2/51	0.2612246682909364	0.403032345363159	0	0	2.063175657860043	2.7695542763549796	PTPN6;PTPN7
Calcium signaling pathway	5/178	0.2659408657872025	0.4073050068267524	0	0	1.4629997591522157	1.937715828732296	PPP3CC;HRH2;ATP2A3;CALM3;PRKACA
Heparan sulfate/heparin glycosaminoglycan (HS-GAG) metabolism	2/52	0.2684597858467117	0.4073050068267524	0	0	2.0218087855297155	2.6587880331757026	B3GAT3;B4GALT7
Amino acid biosynthesis and interconversion (transamination)	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	GOT2
Control of cell cycle and breast tumor growth by estrogen-responsive protein Efp	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	CDK6
Gap-filling DNA repair biosynthesis and ligation in global genomic nucleotide excision repair	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	RPA1
GluR2-containing AMPA receptor trafficking	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	AP2S1
Glyoxylate and dicarboxylate metabolism	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	MDH2
KIT signaling regulation	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	PTPN6
LPA4-mediated signaling events	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	PRKACA
Protein kinase A (PKA) at the centrosome	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	PPP1CA
Rap1 signaling	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	PRKACA
Selenium metabolism and selenoproteins	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	SCLY
p75 neurotrophin receptor signaling via NF-kB	1/16	0.26976192173275104	0.4073050068267524	0	0	3.3670103092783505	4.411509029657272	MYD88
Amyotrophic lateral sclerosis (ALS)	2/53	0.2756936518216138	0.4111834979429982	0	0	1.982064143486852	2.553820250656324	DAXX;PPP3CC
GABA A and B receptor activation	2/53	0.2756936518216138	0.4111834979429982	0	0	1.982064143486852	2.553820250656324	GNB2;GNAI2
JNK/MAPK pathway	2/53	0.2756936518216138	0.4111834979429982	0	0	1.982064143486852	2.553820250656324	CDC42;RAC2
Starch and sucrose metabolism	2/53	0.2756936518216138	0.4111834979429982	0	0	1.982064143486852	2.553820250656324	PYGB;HK1
ERBB signaling pathway	3/94	0.276380486207188	0.4111834979429982	0	0	1.667141149006434	2.143904822292899	PIK3CD;AKT1;HRAS
Adrenergic pathway	4/137	0.27712348608724807	0.4111834979429982	0	0	1.5215701591641442	1.9526189252664692	RGS19;AKT1;PRKACA;HRAS
Innate immune system	8/319	0.2825659024285772	0.4111834979429982	0	0	1.3030525525145369	1.6468544630399904	SIGIRR;PYCARD;PRKCSH;RPS6KA1;IRAK4;MYD88;DDOST;DUSP7
RANKL signaling pathway	2/54	0.2829235844566386	0.4111834979429982	0	0	1.9438481415225601	2.454260749044291	CDC42;AKT1
Acyl chain remodelling of phosphatidylglycerol	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	LPCAT4
Acyl chain remodelling of phosphatidylserine	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	LPCAT4
Atypical NF-kappaB pathway	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	ARRB2
Beta-arrestin-dependent recruitment of Src kinases in GPCR signaling	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	HRAS
Cadmium-induced DNA biosynthesis and proliferation in macrophages	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	HRAS
Cell to cell adhesion signaling	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	CSK
Destabilization of mRNA by KSRP	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	AKT1
GRB2-SOS provides linkage to MAPK signaling for integrins	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	TLN1
Inflammasomes	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	PYCARD
Integrin beta-5 pathway	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	ITGB7
Ion channel function in vascular endothelium	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	AKT1
Nitric oxide metabolism	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	AKT1
Phenylalanine metabolism	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	GOT2
Platelet sensitization by LDL	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	PTPN6
Renin-angiotensin system	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	CTSA
SHC-related events	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	HRAS
SHC1 events in EGFR signaling	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	HRAS
SUMOylation by RanBP2 regulates transcriptional repression	1/17	0.28397640271880265	0.4111834979429982	0	0	3.156411082474227	3.97349270165002	NUP210
Meiotic synapsis	2/55	0.2901470062628076	0.418139641678583	0	0	1.9070742528399396	2.359751826977752	SYCE2;RAD21
TAp63 pathway	2/55	0.2901470062628076	0.418139641678583	0	0	1.9070742528399396	2.359751826977752	FLOT2;PML
Vibrio cholerae infection	2/55	0.2901470062628076	0.418139641678583	0	0	1.9070742528399396	2.359751826977752	PRKACA;ACTB
Cytosolic DNA-sensing pathway	2/56	0.297361441036317	0.42269840399369313	0	0	1.871662360034453	2.2699650376435456	PYCARD;TMEM173
Bone remodeling	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	EIF2AK2
CDK regulation of DNA replication	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	CDT1
Downregulation of MTA-3 in ER-negative breast tumors	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	CTSD
Fatty acyl-CoA biosynthesis	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	ELOVL1
Human cytomegalovirus and MAP kinase pathways	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	AKT1
Nucleotide di- and triphosphate biosynthesis and interconversion	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	AK2
PKA activation in glucagon signaling	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	PRKACA
Pertussis toxin-insensitive CCR5 signaling in macrophage	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	CALM3
Phosphatidylcholine biosynthesis	1/18	0.2979148882177772	0.42269840399369313	0	0	2.9705882352941178	3.597226228562596	SLC44A2
Granule cell survival pathway	3/99	0.302908963388281	0.4284598280284159	0	0	1.5799060880829014	1.8869181306201714	KCNK5;AKT1;PRKACA
Senescence and autophagy	3/99	0.302908963388281	0.4284598280284159	0	0	1.5799060880829014	1.8869181306201714	FKBP8;HRAS;CDC25B
Keratinocyte differentiation	2/57	0.30456451077857566	0.43013880137651145	0	0	1.8375381724218933	2.184598336678941	DAXX;HRAS
Transmission across chemical synapses	5/190	0.31102098812536927	0.43165929190673274	0	0	1.367257882882883	1.59681348536038	GNB2;RPS6KA1;AP2S1;HRAS;GNAI2
Cell cycle progression regulation by PLK3	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	YWHAH
Destabilization of mRNA by butyrate response factor 1 (BRF1)	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	AKT1
ER-associated degradation (ERAD) pathway	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	MAN2B1
Eicosanoid biosynthesis	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	GGT1
FRS2-mediated activation	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	HRAS
Inhibition of T cell receptor signaling by activated Csk	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	CSK
Mitochondrial gene expression	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	HCFC1
Platelet calcium homeostasis	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	ATP2A3
STAT3 pathway	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	RAC2
Signaling by constitutively active EGFR	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	HRAS
Telomeres, telomerase, cellular aging, and immortality	1/19	0.311582723495059	0.43165929190673274	0	0	2.8054123711340204	3.271364464932353	AKT1
HIV-1 Nef as negative effector of Fas and TNF	2/58	0.31175393304375143	0.43165929190673274	0	0	1.8046327057954965	2.1033735501788007	DAXX;ARHGDIB
RNA polymerase II transcription	3/101	0.31355896062938204	0.4328528208387559	0	0	1.5475044940255895	1.794745982200132	SLBP;RBM8A;NELFCD
TNF-alpha signaling pathway	3/101	0.31355896062938204	0.4328528208387559	0	0	1.5475044940255895	1.794745982200132	AKT1;CYBA;PTPRCAP
Signaling by ERBB2	3/102	0.3188877926381674	0.43954803850125773	0	0	1.531794630240226	1.750712569083906	AKT1;PRKACA;HRAS
Chromosome maintenance	3/103	0.32421776013018405	0.44086059767485236	0	0	1.51639896373057	1.7079806416709018	SYCE2;RAD21;RPA1
Dual incision reaction in GG-NER	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	RPA1
Gene expression regulation in pancreatic beta cells	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	AKT1
Hypertrophy pathway	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	WDR1
ID regulation of gene expression	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	SMARCC1
N-glycan antennae elongation in the medial/trans-Golgi	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	B4GALT5
Nerve growth factor (NGF) pathway	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	HRAS
Peroxisomal lipid metabolism	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	ABCD1
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	AKT1
Sprouty regulation of tyrosine kinase signals	1/20	0.32498515061856786	0.44086059767485236	0	0	2.6576234400434076	2.9871044004975347	HRAS
Ephrin receptor B forward pathway	2/60	0.32608316538259774	0.44086059767485236	0	0	1.7422257863316404	1.952343132052782	CDC42;HRAS
RAGE pathway	2/60	0.32608316538259774	0.44086059767485236	0	0	1.7422257863316404	1.952343132052782	ITGB1;CYBA
Selenium pathway	2/60	0.32608316538259774	0.44086059767485236	0	0	1.7422257863316404	1.952343132052782	GGT1;XDH
Clathrin derived vesicle budding	2/61	0.33321886279873786	0.4485262698669228	0	0	1.712608943196251	1.8820814614705696	CTSZ;AP1S1
FGF signaling pathway	2/61	0.33321886279873786	0.4485262698669228	0	0	1.712608943196251	1.8820814614705696	RPS6KA1;AKT1
Ion channel transport	2/61	0.33321886279873786	0.4485262698669228	0	0	1.712608943196251	1.8820814614705696	ATP8B2;ATP2A3
CD28-dependent PI3K/Akt signaling	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	AKT1
IGF1 signaling pathway	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	HRAS
Mitochondrial role in apoptotic signaling	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	BAK1
Mitochondrial tRNA aminoacylation	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	QARS
PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	VAV1
Presynaptic function of kainate receptors	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	GNB2
S1P/S1P1 pathway	1/21	0.3381273103930354	0.4505092466484855	0	0	2.524613402061856	2.737521110211272	GNAI2
G alpha (i) signaling events	5/199	0.34548561531377164	0.4596460795044093	0	0	1.3032243341924399	1.385072388508361	RGS19;GNB2;S1PR2;S1PR4;GNAI2
G alpha i pathway	3/108	0.3508489310645357	0.46497990789257515	0	0	1.443819393042191	1.5122557738772813	RGS19;AKT1;HRAS
CTLA4 inhibitory signaling	1/22	0.3510142441934146	0.46497990789257515	0	0	2.4042709867452134	2.5170997566591327	AKT1
Double-strand break repair	1/22	0.3510142441934146	0.46497990789257515	0	0	2.4042709867452134	2.5170997566591327	RPA1
Validated nuclear estrogen receptor alpha network	2/64	0.3544873820952238	0.4689040587369099	0	0	1.6294907060098358	1.689916339386885	AXIN2;CTSD
Interleukin-12-mediated signaling events	2/65	0.36152480779458196	0.47690217517774325	0	0	1.6035437430786268	1.6314848756510634	IL2RB;GADD45G
Angiogenesis	1/23	0.363650896105033	0.47690217517774325	0	0	2.294868791002812	2.32139965019429	AKT1
Mismatch repair	1/23	0.363650896105033	0.47690217517774325	0	0	2.294868791002812	2.32139965019429	RPA1
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	1/23	0.363650896105033	0.47690217517774325	0	0	2.294868791002812	2.32139965019429	CDK6
Post-elongation processing of intronless pre-mRNA	1/23	0.363650896105033	0.47690217517774325	0	0	2.294868791002812	2.32139965019429	SLBP
Signaling events mediated by PRL	1/23	0.363650896105033	0.47690217517774325	0	0	2.294868791002812	2.32139965019429	ITGB1
Signaling by TGF-beta receptor complex	2/66	0.36853344046384967	0.4826158321623594	0	0	1.578407622739018	1.575604092910764	E2F4;PPP1CA
Adipocytokine signaling pathway	2/67	0.37551173883142985	0.4875800300152689	0	0	1.554044921486782	1.5221334581520214	RXRA;AKT1
G alpha 13 pathway	2/67	0.37551173883142985	0.4875800300152689	0	0	1.554044921486782	1.5221334581520214	CDC42;AKT1
Cholesterol biosynthesis	1/24	0.37604211465229886	0.4875800300152689	0	0	2.1949798296727923	2.1468090982372923	LBR
Cytosolic tRNA aminoacylation	1/24	0.37604211465229886	0.4875800300152689	0	0	2.1949798296727923	2.1468090982372923	QARS
NF-kappaB signaling pathway	1/24	0.37604211465229886	0.4875800300152689	0	0	2.1949798296727923	2.1468090982372923	MYD88
Triacylglyceride biosynthesis	1/24	0.37604211465229886	0.4875800300152689	0	0	2.1949798296727923	2.1468090982372923	AGPAT3
Tumor suppressor Arf inhibits ribosomal biogenesis	1/24	0.37604211465229886	0.4875800300152689	0	0	2.1949798296727923	2.1468090982372923	AKT1
AMPK signaling	2/68	0.3824582322875284	0.49425916365710393	0	0	1.530420483908856	1.470941959467154	PIK3CD;AKT1
Epithelial cell signaling in Helicobacter pylori infection	2/68	0.3824582322875284	0.49425916365710393	0	0	1.530420483908856	1.470941959467154	CDC42;CSK
Alpha-9 beta-1 integrin pathway	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	ITGB1
C-Myc pathway	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	PML
Ck1/Cdk5 regulation by type 1 glutamate receptors	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	PPP1CA
Fatty acid biosynthesis	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	ACAA2
Glutathione conjugation	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	GGT1
IGF1 receptor signaling through beta-arrestin	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	AKT1
Interferon alpha signaling regulation	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	PTPN6
PIP2 hydrolysis	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	DGKD
RNA polymerase I transcription initiation	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	EHMT2
SHC1 events in ERBB2 signaling	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	HRAS
TPO signaling pathway	1/25	0.3881926546805794	0.49425916365710393	0	0	2.1034149484536084	1.9903638198365734	HRAS
G alpha q pathway	2/70	0.39625026140162795	0.5017348137471648	0	0	1.4852561179510564	1.3749153925094661	RGS19;AKT1
Hedgehog signaling pathway	2/70	0.39625026140162795	0.5017348137471648	0	0	1.4852561179510564	1.3749153925094661	ARRB2;PRKACA
Long-term depression	2/70	0.39625026140162795	0.5017348137471648	0	0	1.4852561179510564	1.3749153925094661	HRAS;GNAI2
Nucleotide metabolism	2/70	0.39625026140162795	0.5017348137471648	0	0	1.4852561179510564	1.3749153925094661	AK2;XDH
Acyl chain remodelling of phosphatidylcholine	1/26	0.40010717905576887	0.5031484799632819	0	0	2.0191752577319586	1.849610613916858	LPCAT4
Galactose metabolism	1/26	0.40010717905576887	0.5031484799632819	0	0	2.0191752577319586	1.849610613916858	HK1
Interleukin-9 regulation of target genes	1/26	0.40010717905576887	0.5031484799632819	0	0	2.0191752577319586	1.849610613916858	CDKN2D
Physiological and pathological hypertrophy  of the heart	1/26	0.40010717905576887	0.5031484799632819	0	0	2.0191752577319586	1.849610613916858	CALM3
RXR/VDR pathway	1/26	0.40010717905576887	0.5031484799632819	0	0	2.0191752577319586	1.849610613916858	RXRA
HIV life cycle	3/118	0.40364383494886064	0.5069015601683367	0	0	1.3175940527145753	1.1953508209644637	NUP210;NUP50;NELFCD
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	3/119	0.4088640682774635	0.5115337744695363	0	0	1.306168483115955	1.1682012103022794	ITGB1;TRAC;ITGB7
Cooperation of prefoldin and TriC/CCT  in actin and tubulin folding	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	ACTB
Glucuronidation	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	HK1
Glycolysis	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	HK1
Glycosphingolipid biosynthesis: lacto and neolacto series	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	FUT7
Pentose phosphate pathway	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	TALDO1
RORA activates circadian expression	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	RXRA
eIF4E and p70 S6 kinase regulation	1/27	0.41179026071131514	0.5115337744695363	0	0	1.941415543219667	1.7225037304595354	AKT1
G alpha s pathway	3/120	0.41407045028970774	0.5136711802242591	0	0	1.2949382223993624	1.1417718285650265	PYGB;RGS19;PRKACA
Signaling by NOTCH1	2/73	0.41666682190173904	0.5161945242993204	0	0	1.4222804527422936	1.245161542234786	ARRB2;HDAC7
Extension of telomeres	1/28	0.42324638412418314	0.5196214882491768	0	0	1.8694158075601375	1.6073252089778878	RPA1
Multi-step regulation of transcription by PITX2	1/28	0.42324638412418314	0.5196214882491768	0	0	1.8694158075601375	1.6073252089778878	KREMEN2
PTM: gamma carboxylation, hypusine formation and arylsulfatase activation	1/28	0.42324638412418314	0.5196214882491768	0	0	1.8694158075601375	1.6073252089778878	ARSB
TGF-beta receptor activation of SMADs	1/28	0.42324638412418314	0.5196214882491768	0	0	1.8694158075601375	1.6073252089778878	PPP1CA
TRAIL signaling pathway	1/28	0.42324638412418314	0.5196214882491768	0	0	1.8694158075601375	1.6073252089778878	PIK3CD
Integrins in angiogenesis	2/74	0.42339528672155147	0.5196214882491768	0	0	1.402454780361757	1.2053384319020017	AKT1;TLN1
Seven transmembrane receptor signaling through beta-arrestin	2/74	0.42339528672155147	0.5196214882491768	0	0	1.402454780361757	1.2053384319020017	AKT1;ACTB
Signaling by PDGF	3/122	0.42443884671047916	0.5202067573834711	0	0	1.2730439325989462	1.0909825375534068	AKT1;PRKACA;HRAS
ADP-ribosylation factor	1/29	0.4344799470148749	0.5289822166573676	0	0	1.802558910162003	1.5026229985235093	ARHGAP4
CDO in myogenesis	1/29	0.4344799470148749	0.5289822166573676	0	0	1.802558910162003	1.5026229985235093	CDC42
Homologous recombination	1/29	0.4344799470148749	0.5289822166573676	0	0	1.802558910162003	1.5026229985235093	RPA1
Integrin beta-2 pathway	1/29	0.4344799470148749	0.5289822166573676	0	0	1.802558910162003	1.5026229985235093	THY1
Post-translational modification: biosynthesis of GPI-anchored proteins	1/29	0.4344799470148749	0.5289822166573676	0	0	1.802558910162003	1.5026229985235093	PIGT
G alpha (s) signaling events	3/125	0.4398704520313498	0.5341284060380675	0	0	1.2415484583368726	1.019652738208794	HRH2;GNB2;GNAI2
Interleukin-1 signaling pathway	3/125	0.4398704520313498	0.5341284060380675	0	0	1.2415484583368726	1.019652738208794	AKT1;IRAK4;MYD88
Transcriptional regulation of white adipocyte differentiation	2/77	0.44333502487315957	0.5345943145991442	0	0	1.3461498708010335	1.094998057978417	CCND3;RXRA
Activation of kainate receptors upon glutamate binding	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	GNB2
Glutamate binding and activation of AMPA receptors and synaptic plasticity	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	AP2S1
Inflammatory response pathway	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	IL2RB
MicroRNAs in muscle cell differentiation	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	PRKACA
O-glycan biosynthesis	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	B4GALT5
PDGFA signaling pathway	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	HRAS
TNFR1 signaling pathway	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	ARHGDIB
p38-alpha and p38-beta regulation	1/30	0.44549526216595353	0.5345943145991442	0	0	1.7403128332740847	1.4071624277575288	CDC42
Peroxisome	2/78	0.4498966298055336	0.5391711568687727	0	0	1.3283693730450157	1.0610183446277834	ABCD1;XDH
Signaling by FGFR in disease	3/128	0.4551417264526376	0.5418890571950727	0	0	1.2115647668393783	0.9536788710256532	AKT1;PRKACA;HRAS
Activated NOTCH1 signaling in the nucleus	1/31	0.4562965590542388	0.5418890571950727	0	0	1.6822164948453608	1.3198878070331481	ARRB2
Alpha-V beta-3 integrin/OPN pathway	1/31	0.4562965590542388	0.5418890571950727	0	0	1.6822164948453608	1.3198878070331481	CDC42
CD40/CD40L signaling	1/31	0.4562965590542388	0.5418890571950727	0	0	1.6822164948453608	1.3198878070331481	AKT1
DNA strand elongation	1/31	0.4562965590542388	0.5418890571950727	0	0	1.6822164948453608	1.3198878070331481	RPA1
Inwardly rectifying potassium channels	1/31	0.4562965590542388	0.5418890571950727	0	0	1.6822164948453608	1.3198878070331481	GNB2
NF-kappaB activation by non-typeable Hemophilus influenzae	1/31	0.4562965590542388	0.5418890571950727	0	0	1.6822164948453608	1.3198878070331481	MYD88
Alanine, aspartate and glutamate metabolism	1/32	0.4668879854101972	0.5516128321834762	0	0	1.6278683072830062	1.2398917956587323	GOT2
Hypothetical network for drug addiction	1/32	0.4668879854101972	0.5516128321834762	0	0	1.6278683072830062	1.2398917956587323	PRKACA
Pancreatic beta-cell development regulation	1/32	0.4668879854101972	0.5516128321834762	0	0	1.6278683072830062	1.2398917956587323	AKT1
Serotonin HTR1 group and FOS pathway	1/32	0.4668879854101972	0.5516128321834762	0	0	1.6278683072830062	1.2398917956587323	GNAI2
Transcription	4/181	0.4693658129666457	0.5538275273822375	0	0	1.140744001760951	0.8628277684184588	SLBP;RBM8A;EHMT2;NELFCD
Neuronal system	6/283	0.4732703352823661	0.5577178020400668	0	0	1.0934386517235204	0.8179889031014439	GNB2;RPS6KA1;AP2S1;KCNAB2;HRAS;GNAI2
SMAD2/3 nuclear pathway	2/82	0.4756964741585302	0.5598581580481163	0	0	1.2616925064599482	0.9374063526892497	AKT1;E2F4
Global genomic nucleotide excision repair (GG-NER)	1/33	0.4772736086170998	0.560277714463552	0	0	1.576916881443299	1.1663907763559687	RPA1
Glucagon-type ligand receptors	1/33	0.4772736086170998	0.560277714463552	0	0	1.576916881443299	1.1663907763559687	GNB2
Adipogenesis	3/133	0.4801954362237327	0.5629877528140314	0	0	1.1646671980868872	0.8543557146367481	BSCL2;RXRA;E2F4
Cysteine and methionine metabolism	1/34	0.48745741766623846	0.5693204954422479	0	0	1.529053420805998	1.0987049146309562	GOT2
Fructose and mannose metabolism	1/34	0.48745741766623846	0.5693204954422479	0	0	1.529053420805998	1.0987049146309562	HK1
Interleukin-7 interactions in immune response	1/34	0.48745741766623846	0.5693204954422479	0	0	1.529053420805998	1.0987049146309562	CDKN2D
ECM-receptor interaction	2/84	0.4883186899484502	0.569601724742919	0	0	1.230793470725405	0.8822168002430284	ITGB1;ITGB7
C-Myb transcription factor network	2/85	0.4945582347717583	0.5736846377019812	0	0	1.215902369166589	0.8561051488627874	CDK6;HRAS
Myc active pathway	2/85	0.4945582347717583	0.5736846377019812	0	0	1.215902369166589	0.8561051488627874	PTMA;CDC25A
Ubiquitin-mediated proteolysis	3/136	0.49496592072284834	0.5736846377019812	0	0	1.138221200670069	0.8004726872809269	KEAP1;TRIM37;PML
Arf6 signal transduction regulation	1/35	0.49744332419474624	0.5736846377019812	0	0	1.4840054578532444	1.0362419078080654	ARRB2
Ether lipid metabolism	1/35	0.49744332419474624	0.5736846377019812	0	0	1.4840054578532444	1.0362419078080654	LPCAT4
Interleukin-7 signaling pathway	1/35	0.49744332419474624	0.5736846377019812	0	0	1.4840054578532444	1.0362419078080654	AKT1
Linoleic acid metabolism	1/35	0.49744332419474624	0.5736846377019812	0	0	1.4840054578532444	1.0362419078080654	ABCD1
Primary immunodeficiency	1/35	0.49744332419474624	0.5736846377019812	0	0	1.4840054578532444	1.0362419078080654	TAP2
Prion diseases	1/35	0.49744332419474624	0.5736846377019812	0	0	1.4840054578532444	1.0362419078080654	PRKACA
Diabetes pathways	3/137	0.49984298787153025	0.5757288116261792	0	0	1.1296690124506998	0.7833816901290537	RAB27A;TLN1;ACTB
Signaling to ERKs	1/36	0.5072351643788231	0.5820523511246994	0	0	1.4415316642120766	0.9784836527949775	HRAS
Steroid hormone, vitamin A, and vitamin D metabolism	1/36	0.5072351643788231	0.5820523511246994	0	0	1.4415316642120766	0.9784836527949775	HSD11B1
Transport to the Golgi and subsequent modification	1/36	0.5072351643788231	0.5820523511246994	0	0	1.4415316642120766	0.9784836527949775	B4GALT5
Allograft rejection	1/37	0.5168367001648603	0.5908544094039124	0	0	1.4014175257731958	0.9249752478451913	PRF1
Latent infection of Homo sapiens with Mycobacterium tuberculosis	1/37	0.5168367001648603	0.5908544094039124	0	0	1.4014175257731958	0.9249752478451913	CYBA
PI3K/AKT activation	1/37	0.5168367001648603	0.5908544094039124	0	0	1.4014175257731958	0.9249752478451913	AKT1
Salivary secretion	2/89	0.5190276528312102	0.5926211259938445	0	0	1.1597612046689834	0.760569213322491	CALM3;PRKACA
Influenza infection	3/142	0.5238615091092687	0.5956830923478208	0	0	1.0887538673724233	0.7039097789108845	NUP210;NUP50;EIF2AK2
BMAL1-CLOCK/NPAS2 activates circadian expression	1/38	0.5262516207996544	0.5956830923478208	0	0	1.3634717191418222	0.8753158668792511	RXRA
EGFR interaction with phospholipase C-gamma	1/38	0.5262516207996544	0.5956830923478208	0	0	1.3634717191418222	0.8753158668792511	PRKACA
ERBB4 signaling events	1/38	0.5262516207996544	0.5956830923478208	0	0	1.3634717191418222	0.8753158668792511	PIK3CD
Nuclear receptors	1/38	0.5262516207996544	0.5956830923478208	0	0	1.3634717191418222	0.8753158668792511	RXRA
Signal transduction through IL-1R	1/38	0.5262516207996544	0.5956830923478208	0	0	1.3634717191418222	0.8753158668792511	MYD88
p38 alpha/beta MAPK downstream pathway	1/38	0.5262516207996544	0.5956830923478208	0	0	1.3634717191418222	0.8753158668792511	RPS6KA4
Signaling by GPCR	19/977	0.5339278822208867	0.6036278274369138	0	0	0.9998504767815832	0.6274006761657461	DGKD;RGS19;VAV1;ARHGAP4;GNAI2;PPP1CA;CDC42;PPP3CC;HRH2;GNB2;RPS6KA1;RAC2;AKT1;ARHGEF2;S1PR2;PRKACA;HRAS;S1PR4;F2RL3
FRS2-mediated cascade	1/39	0.535483544034845	0.6038991319705008	0	0	1.3275230602278894	0.829151149424075	HRAS
Vitamin A and carotenoid metabolism	1/39	0.535483544034845	0.6038991319705008	0	0	1.3275230602278894	0.829151149424075	RXRA
Signaling by ERBB4	2/93	0.5426958110749321	0.6112819074439113	0	0	1.1085555271601784	0.6775561405219148	AKT1;HRAS
PAC1 receptor pathway	1/40	0.5445360179787202	0.6126030202260602	0	0	1.2934179222839017	0.7861668207877148	PRKACA
FOXM1 transcription factor network	1/41	0.5534125217850969	0.6195520670716086	0	0	1.2610180412371135	0.74608332265938	CDC25B
Graft-versus-host disease	1/41	0.5534125217850969	0.6195520670716086	0	0	1.2610180412371135	0.74608332265938	PRF1
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	1/41	0.5534125217850969	0.6195520670716086	0	0	1.2610180412371135	0.74608332265938	E2F4
Tyrosine metabolism	1/41	0.5534125217850969	0.6195520670716086	0	0	1.2610180412371135	0.74608332265938	GOT2
Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	2/96	0.5599094613279234	0.6239696701398825	0	0	1.0730111605915664	0.6223252109162989	SLC14A1;SLC44A2
Amine ligand-binding G-protein coupled receptors	1/42	0.5621164675443168	0.6239696701398825	0	0	1.2301986421926074	0.7086512689938842	HRH2
BMP receptor signaling	1/42	0.5621164675443168	0.6239696701398825	0	0	1.2301986421926074	0.7086512689938842	PPP1CA
Fatty acid metabolism	1/42	0.5621164675443168	0.6239696701398825	0	0	1.2301986421926074	0.7086512689938842	ACAA2
Messenger RNA splicing: minor pathway	1/42	0.5621164675443168	0.6239696701398825	0	0	1.2301986421926074	0.7086512689938842	SNRPD1
TWEAK signaling pathway	1/42	0.5621164675443168	0.6239696701398825	0	0	1.2301986421926074	0.7086512689938842	AKT1
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling	1/42	0.5621164675443168	0.6239696701398825	0	0	1.2301986421926074	0.7086512689938842	ITGB1
Translation	3/151	0.5654443353293926	0.6262596400232574	0	0	1.022073239042151	0.5827283347593362	RPN2;EIF4H;DDOST
TSH regulation of gene expression	2/97	0.565543836143007	0.6262596400232574	0	0	1.0616619067047464	0.605112749830296	DUSP2;CYBA
Beta-3 integrin cell surface interactions	1/43	0.5706512012432368	0.6286497072568256	0	0	1.2008468335787923	0.673647588584474	THY1
Mitotic prometaphase	1/43	0.5706512012432368	0.6286497072568256	0	0	1.2008468335787923	0.673647588584474	RAD21
Type 1 diabetes mellitus	1/43	0.5706512012432368	0.6286497072568256	0	0	1.2008468335787923	0.673647588584474	PRF1
Voltage-gated potassium channels	1/43	0.5706512012432368	0.6286497072568256	0	0	1.2008468335787923	0.673647588584474	KCNAB2
Wnt signaling pathway and pluripotency	2/98	0.571126204632018	0.6286497072568256	0	0	1.0505490956072352	0.5884598965653686	CCND3;AXIN2
Potassium channels	2/99	0.5766564533863965	0.6339767954595352	0	0	1.0396654146354458	0.572344742736461	GNB2;KCNAB2
Lysine degradation	1/44	0.5790200041843286	0.634296376898823	0	0	1.1728602253656197	0.6408722347297636	EHMT2
PI3K events in ERBB2 signaling	1/44	0.5790200041843286	0.634296376898823	0	0	1.1728602253656197	0.6408722347297636	AKT1
Valine, leucine and isoleucine degradation	1/44	0.5790200041843286	0.634296376898823	0	0	1.1728602253656197	0.6408722347297636	ACAA2
Interleukin-12/STAT4 pathway	1/45	0.5872260941523975	0.6405942003164049	0	0	1.1461457357075915	0.6101453693293315	PRF1
RNA polymerase III transcription	1/45	0.5872260941523975	0.6405942003164049	0	0	1.1461457357075915	0.6101453693293315	NONO
Signaling by FGFR mutants	1/45	0.5872260941523975	0.6405942003164049	0	0	1.1461457357075915	0.6101453693293315	HRAS
Pancreatic secretion	2/101	0.58756025780655	0.6405942003164049	0	0	1.0185576697204604	0.5416450038719108	ATP2A3;RAB8A
Polo-like kinase 1 (PLK1) pathway	1/46	0.5952726269105891	0.6466985461584862	0	0	1.120618556701031	0.5813049432085999	CDC25B
Syndecan 1 pathway	1/46	0.5952726269105891	0.6466985461584862	0	0	1.120618556701031	0.5813049432085999	PRKACA
Transfer RNA aminoacylation	1/46	0.5952726269105891	0.6466985461584862	0	0	1.120618556701031	0.5813049432085999	QARS
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.6031626968133984	0.6529520703711081	0	0	1.0962012550425817	0.5542046119345135	PYCARD
Regulation of NFAT transcription factors	1/47	0.6031626968133984	0.6529520703711081	0	0	1.0962012550425817	0.5542046119345135	CALM3
Regulation of transcription by NOTCH1 intracellular domain	1/47	0.6031626968133984	0.6529520703711081	0	0	1.0962012550425817	0.5542046119345135	HDAC7
Amoebiasis	2/105	0.6087400030726648	0.6582135722269803	0	0	0.9788013346378666	0.4858417718759498	PIK3CD;PRKACA
Activation of chaperones by IRE1 alpha	1/48	0.6108993386817457	0.6589959963687927	0	0	1.0728229874972581	0.5287119309866237	TLN1
Intestinal immune network for IgA production	1/48	0.6108993386817457	0.6589959963687927	0	0	1.0728229874972581	0.5287119309866237	ITGB7
Neuroactive ligand-receptor interaction	5/272	0.6124352799568098	0.6598774495309288	0	0	0.9433520599250936	0.4625368423027086	HRH2;TSPO;S1PR2;S1PR4;F2RL3
Arf6 integrin-mediated signaling pathway	1/49	0.6184855284865509	0.6656151408565694	0	0	1.0504188144329898	0.504706792021385	ITGB1
Protein metabolism	8/442	0.6310955714750569	0.6782897070661327	0	0	0.9278033794162827	0.42706600984902415	PIGT;RPN2;PRKCSH;EIF4H;DDOST;ACTB;ARSB;B4GALT5
Glutathione metabolism	1/51	0.6332181687970323	0.6782897070661327	0	0	1.0082989690721649	0.4607323908389874	GGT1
Malaria	1/51	0.6332181687970323	0.6782897070661327	0	0	1.0082989690721649	0.4607323908389874	MYD88
Nuclear receptor transcription pathway	1/51	0.6332181687970323	0.6782897070661327	0	0	1.0082989690721649	0.4607323908389874	RXRA
Autoimmune thyroid disease	1/52	0.6403702878589096	0.6827641396683843	0	0	0.9884778653729533	0.44057317956866576	PRF1
Drug metabolism: other enzymes	1/52	0.6403702878589096	0.6827641396683843	0	0	0.9884778653729533	0.44057317956866576	XDH
Pyruvate metabolism	1/52	0.6403702878589096	0.6827641396683843	0	0	0.9884778653729533	0.44057317956866576	MDH2
Taste transduction	1/52	0.6403702878589096	0.6827641396683843	0	0	0.9884778653729533	0.44057317956866576	PRKACA
Lipid metabolism regulation by peroxisome proliferator-activated receptor alpha (PPAR-alpha)	2/112	0.6437952621911783	0.6856195483660112	0	0	0.9161851068827813	0.40346457601128854	RXRA;TEAD1
Protein folding	1/53	0.6473832939220887	0.688641788899742	0	0	0.969419111816019	0.4215196605117257	ACTB
Arginine and proline metabolism	1/54	0.6542598860449516	0.693545699063817	0	0	0.9510795565065162	0.4034960983512396	GOT2
Meiotic recombination	1/54	0.6542598860449516	0.693545699063817	0	0	0.9510795565065162	0.4034960983512396	RPA1
Phospholipase C-mediated cascade	1/54	0.6542598860449516	0.693545699063817	0	0	0.9510795565065162	0.4034960983512396	PRKACA
Basal cell carcinoma	1/55	0.6610027108707596	0.6990789038932687	0	0	0.9334192439862543	0.3864330822229019	AXIN2
RNA polymerase I transcription	1/55	0.6610027108707596	0.6990789038932687	0	0	0.9334192439862543	0.3864330822229019	EHMT2
TGF-beta regulation of extracellular matrix	10/565	0.66354757585969	0.7009628016561513	0	0	0.9059402410325893	0.37157566897325345	CDC42;CAP1;CDK6;LIMK2;E2F2;E2F4;AXIN2;CDC25A;CDC25B;PPP1CA
Steroid hormone biosynthesis	1/56	0.6676143640436556	0.7044482599908919	0	0	0.9164011246485473	0.3702668997149404	HSD11B1
Activation of mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	1/57	0.6740973908050745	0.7088446789909031	0	0	0.8999907952871871	0.35493898342762586	EIF4H
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	1/57	0.6740973908050745	0.7088446789909031	0	0	0.8999907952871871	0.35493898342762586	RXRA
PI3K cascade	1/57	0.6740973908050745	0.7088446789909031	0	0	0.8999907952871871	0.35493898342762586	AKT1
Arachidonic acid metabolism	1/58	0.6804542871815321	0.71341175418898	0	0	0.8841562669560499	0.3403954188255951	GGT1
Nucleotide excision repair	1/58	0.6804542871815321	0.71341175418898	0	0	0.8841562669560499	0.3403954188255951	RPA1
Interleukin-1 regulation of extracellular matrix	2/120	0.6807720007293534	0.71341175418898	0	0	0.8537204922699602	0.3282792879622441	HSD11B1;LCP1
Telomere maintenance	1/59	0.6866875009709518	0.7187903373903463	0	0	0.8688677568432279	0.3265865066538658	RPA1
HIV genome transcription	1/61	0.6987924353979638	0.7306280816575521	0	0	0.839819587628866	0.30099262169742047	NELFCD
Circadian rhythm	1/62	0.7046688182993311	0.7359339877119294	0	0	0.8260098022646611	0.2891260203598641	RXRA
O-linked glycosylation of mucins	1/63	0.7104308446707377	0.7403442472666623	0	0	0.8126454938476887	0.27783022344723596	B4GALT5
Spliceosome	2/127	0.7105046643158274	0.7403442472666623	0	0	0.8056227390180879	0.27534555173402137	RBM8A;SNRPD1
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	1/64	0.7160807343474219	0.7453085194228269	0	0	0.7997054491899853	0.2670715198438161	ARRB2
Beta-1 integrin cell surface interactions	1/66	0.727052768576038	0.755871394737036	0	0	0.7750198255352895	0.247042390068221	ITGB1
Telomerase regulation	1/67	0.7323791410856552	0.7605475695889496	0	0	0.7632380506091846	0.23771579293119885	AKT1
PPAR signaling pathway	1/69	0.7427228619096473	0.7704176126927189	0	0	0.7407140691328078	0.22031229116626344	RXRA
AP-1 transcription factor network	1/70	0.7477441971866907	0.7738773089260227	0	0	0.729941730165845	0.2121899308523308	MAFG
NCAM signaling for neurite out-growth	1/70	0.7477441971866907	0.7738773089260227	0	0	0.729941730165845	0.2121899308523308	HRAS
Phase II of biological oxidations: conjugation	1/71	0.7526677763195636	0.7772204934323502	0	0	0.7194771723122239	0.20442601928942009	GGT1
RIG-I-like receptor signaling pathway	1/71	0.7526677763195636	0.7772204934323502	0	0	0.7194771723122239	0.20442601928942009	TMEM173
Systemic lupus erythematosus	2/139	0.7560724968524558	0.7798590473152297	0	0	0.7346045757181388	0.2054086711365689	SNRPD1;H2AFV
Cap-dependent translation initiation	1/73	0.7622292222250454	0.7844466659221879	0	0	0.6994201030927835	0.1898981197527671	EIF4H
Myc repressed pathway	1/73	0.7622292222250454	0.7844466659221879	0	0	0.6994201030927835	0.1898981197527671	ITGB1
Interleukin-4 regulation of apoptosis	4/267	0.7657364980356338	0.7871736900299124	0	0	0.7643276875216038	0.20401218006876795	MFNG;WIZ;CDC25A;FKBP5
Unfolded protein response	1/79	0.7887574375971333	0.8099321339084657	0	0	0.6454203013481364	0.1531559369550757	TLN1
Cardiac muscle contraction	1/80	0.7928823684931158	0.8132581165102573	0	0	0.637217799817304	0.14788576549171645	COX5A
NOD signaling pathway	1/85	0.812332614342131	0.8313504347447895	0	0	0.5991347569955817	0.12452740269395492	PYCARD
TGF-beta regulation of skeletal system development	1/85	0.812332614342131	0.8313504347447895	0	0	0.5991347569955817	0.12452740269395492	E2F4
Non-class A, B, C GPCRs	1/86	0.8159982926784787	0.8341719740298925	0	0	0.5920557913887204	0.1203904104542623	CELSR1
Purine metabolism	2/164	0.8314491036432218	0.8490214428748359	0	0	0.6204421475739306	0.11452443325333311	AK2;XDH
Class B GPCRs (secretin family receptors)	1/95	0.8459364756952011	0.8618975412743559	0	0	0.5351228339548146	0.08953194183689002	GNB2
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	1/95	0.8459364756952011	0.8618975412743559	0	0	0.5351228339548146	0.08953194183689002	EHMT2
M phase pathway	1/96	0.8489472793311527	0.8640062111152973	0	0	0.5294628323385784	0.08670387613957543	RAD21
Pyrimidine metabolism	1/100	0.8604148808883053	0.8747074868831276	0	0	0.5079662605435802	0.07636794549370887	CMPK2
DNA repair	1/105	0.8735357993134852	0.8870640085948888	0	0	0.4834208961141951	0.06536148616419939	RPA1
Cytoplasmic ribosomal proteins	1/108	0.8808100865153918	0.893462607095171	0	0	0.4697947779169477	0.05962317838728482	RPS6KA1
Signaling by insulin receptor	1/109	0.8831408812006871	0.8948381114152658	0	0	0.4654209621993127	0.057838115577880524	HRAS
Leptin influence on immune response	1/110	0.88542621053962	0.8961645659044887	0	0	0.4611273999810839	0.0561128207637354	PRF1
GPCR ligand binding	5/410	0.9034937874321488	0.9134441595404323	0	0	0.6174768518518519	0.06266528362673672	HRH2;GNB2;S1PR2;S1PR4;F2RL3
Influenza viral RNA transcription and replication	1/125	0.9148129673494448	0.9238705214816175	0	0	0.4050340871300299	0.03606246992644467	RBM8A
TNF-alpha effects on cytokine activity, cell motility, and apoptosis	1/135	0.9300944453721451	0.9382710998369552	0	0	0.37461532543468223	0.02714805189891676	LFNG
Biological oxidations	1/139	0.9354115448087426	0.942599119796296	0	0	0.363682205289108	0.024282585026279547	GGT1
Oncostatin M	3/311	0.9432167477904233	0.9494221211311498	0	0	0.48708868851355897	0.028474802183580714	HSD11B1;PTPN7;XDH
Class A GPCRs (rhodopsin-like)	2/253	0.9590556362115094	0.9643078576584507	0	0	0.39861226926917653	0.016664460649023296	HRH2;F2RL3
Metapathway biotransformation	1/174	0.967697202424773	0.9719322011224744	0	0	0.2895834574816757	0.009508776325056617	KCNAB2
Peptide G-protein coupled receptors	1/192	0.9773910219037757	0.9805955826313291	0	0	0.26204998110865224	0.005992684720840214	F2RL3
Generic transcription pathway	3/377	0.9787344725020057	0.9808714473327961	0	0	0.3997603280596271	0.008592806846131217	RXRA;E2F4;TEAD1
Olfactory transduction	3/432	0.9909797402490015	0.9920604160835151	0	0	0.3475125910359071	0.003148877130275661	CALM3;ARRB2;PRKACA
Cytokine-cytokine receptor interaction	1/265	0.9946974770643993	0.9946974770643993	0	0	0.1888765229615745	0.0010041868159433888	IL2RB
